complete program

Click on the boxes below to access Each day's Program

As of 21 April 2023

Wednesday 10 May 2023

Day One

Satellite Symposium
Title: International Pachyonychia Congenita Consortium (IPCC) Symposium 

Room: Room G (Takao) – 42F (main tower)
Website and Program: www.pachyonychia.org/2023-ipcc-symposium-at-isid/

Satellite Symposium
Title: AI In Dermatology Symposium 

Room: Room H (Fuji) 42F (main tower)

Access the program HERE

Registration: please fill in the form HERE

Satellite Symposium
Title: Disease Memory and Disease Modification in Psoriasis

Room: Room C  (Nishiki) – 4F (south tower)
Download the PROGRAM: HERE
Website: https://www.psoriasiscouncil.org/event/symposium-isid2023/

Program chairs:  Johann Gudjonsson (Michigan, US) and Curdin Conrad (Lausanne, Switzerland)

Satellite Symposium
Title: Dermatoendocrinology Symposium

Room: Room E (Moonlight)  – 43F (main tower)
Organizers:  M. Böhm, Münster, Germany & R. Paus, Miami, FL, USA & Manchester, UK

PROGRAM

12:00-12:10 Welcome & Introduction
M. Böhm & R. Paus

12:10-12:35 Lecture 1
Is acne vulgaris an endocrine disorder?
M van Steensel (Singapore)

12:35-12:50  Short oral presentation 1
Anti-aging and chemotherapy-protective effects of melatonin in human skin
J. Cheret (Miami, USA)

12:50-13:05  Short oral presentation 2
Targeting alpha7 nicotinic acetylcholine receptors in scleroderma –  why endothelial cells matter
A. Stegemann (Münster, Germany)

13:05-13:30    Lecture 2
Development of an orally-available non-peptide MC1R agonist –basic biology and clinical perspectives
T. Suzuki and K. Belongie (Yokohama, Japan and Jersey City, USA)

13:30-13:35 Mini break

13:35-14:00  Lecture 3
Melasma – pathobiology and future therapies beyond hormones
T. Passeron (Nice, France)

14:00-14:25 Lecture 4
While acetylcholine promotes epidermal differentiation via M3 muscarinic receptor, pemphigus autoantibody eliminates this vital signaling pathway
S. Grando (Los Angeles, USA )

14:25-14:50 Lecture 5
Dissecting the pathobiology and management of androgenetic alopecia in a novel humanized mouse model
A. Gilhar, (Haifa, Israel)

14:50-15:00 Closing Remarks
R. Paus & M. Böhm

Satellite Symposium
Title: Pathophysiological Insights into AD and New Therapeutic Developments
Access the full program HERE

Room: Room H (Fuji) 
Chairs: Kenji Kabashima , Emma Guttman,, and Carolyn Jack

PROGRAM:

12:00 – 12:10 PM Welcome & Program Overview
Robert Bissonnette & Kenji Kabashima| Symposium Co-Chair

12:10 – 12:30 PM Endotypes of Atopic Dermatitis
 Yoshiki Tokura

12:30 – 1:00 PM Neuroinflammatory Circuits 
Gil Yosipovitch

1:00 – 1:15 PM Flash Talk #1 | High-dimensional analysis identifies variably persistent activated skin-homing Th2/Tc2 populations in AD patients on Dupilumab
 Carolyn Jack

1:15 – 1:30 PM Flash Talk #2 | The role of OX40/OX40L axis in atopic dermatitis 
Kazuhiko Yamamura

1:30 – 1:45 PM BREAK

1:45 – 2:05 PM Systemic Inflammation in AD
 Patrick Brunner

2:05 – 2:25 PM Identifying Early Predicting Factors for AD and Atopy
 Helen He

2:25 – 2:45 PM Biomarkers helping with AD therapeutic development
 Emma Guttman

2:45 – 3:00 PM Closing Comments
 Emma Guttman & Carolyn Jack | Symposium Co-Chairs

Satellite Symposium
Title: Cutting-edge Knowledge of Itch in Dermatological Research

Room: Room D (Ohgi) – 4F (south tower)
Organizers: Hiroyuki Murota (Chair), Yozo Ishiuji, Mitsutoshi Tominaga, Kenji Takamori

Satellite Symposium
Title: The 11th Annual Congress Of Pan Asian-Pacific Skin Barrier Research Society (PAPSBRS)

More information coming soon.

Room: Room F (Harmony) –44F (main tower)
Program Book: Download HERE

President : Yutaka Hatano, M.D., Ph.D. Department of Dermatology, Faculty of Medicine, Oita University
Vice-President :Yutaka Takagi, Ph.D. Faculty of Pharmaceutical Sciences, Josai University

Click on the image to access the program

Room: Room A (Concord Ballroom) – 5F  (main tower)

Introduction: Erwin Tschachler

  — LECTURES 1 
Proteomic pathways to personalized medicine
Beatrice Dyring-Andersen (ESDR)

Targeting skin type 3 immunity through understanding the single-cell microenvironment
Tae-Gyun Kim (KSID)

Neutrophils drive skin autoinflammation by releasing interleukin (IL)-26
Jeremy Di Domizio (ESDR)

— COFFEE BREAK —
— LECTURES 2 
Asynthetic fission in the zebrafish skin
Chen-Hui Chen (TSID)

Skin Mechanobiology – Regeneration and More
Yingchao Xue (SID)

“Telescope model” for coordinated organ morphogenesis and stem cell formation.
Ritsuko Morita (JSID)

Single-cell and spatial dissection of human skin homeostasis and cancer.
Andrew Ji (SID)

Room: Room A (Concord Ballroom) – 5F  (main tower)

The winners of the LEO Foundation Awards 2023 will be announced live.

Room: Room A (Concord Ballroom) – 5F  (main tower)
Hosted by: Yukie Yamaguchi

Program:

Opening: Japanese drum ceremony
(Mr. Keita Kanazashi, a professional Wadaiko (Japanese drum) performer)

Welcome remarks
from ISID Meeting Organizer, Professor Kenji Kabashima and
Co-Host, Professor Dong-Youn Lee, President of the Korean Society for Investigative Dermatology (KSID)

Greetings
from Dr. Russell Hall, ISID President

Introduction of ISID Member Societies
Prof. Chris Griffiths

Presidential Remarks

Society for Investigative Dermatology (SID), Prof. Valentina Greco
European Society for Dermatological Research (ESDR), Prof. Sabine Eming
Taiwanese Society for Investigative Dermatology (TSID), Prof. Sung-Jan Lin
Australasian Society for Dermatology Research (ASDR), Prof. Johannes Kern

Introduction of Science Council of Japan
Prof. Masayuki Amagai

Greeting
from the Meeting Co-Organizer: Koichi HISHIDA, Vice-President, Science
Council of Japan

Presentation of a message from the Japanese Prime Minister
Fumio Kishida

Room: Room A (Concord Ballroom) – 5F  (main tower)
Chairs: Kenji Kabashima, Lynn Cornelius and Eli Sprecher

PROGRAM:

15.40-16.00
The misunderstood matrix in dermal fibrosis
Alexander Nystrom (Europe-Middle East-Africa)​

16.00-16.20
Skin microbiota–host interactions in pediatric allergy and atopic dermatitis
Yumi Matsuoka-Nakamura (Asia/Oceania)​ 

16.20-16.40
Immunity to Commensal Virome Regulating the Homeostasis of Aging Skin
Shawn Demehri (Americas) 

Symposium for Platinum Sponsor
Abbvie Symposium

Title: CLEAR horizons
Open Horizons: Up-to-Date Treatment Options for Inflammatory Skin Diseases
Room: Room A (Concord Ballroom) – 5F  (main tower)

PROGRAM:

16:50 – 16:55  Opening
Eung Ho Choi

16:55 – 17:15  Bench to Bedside – AbbVie Development History
Annette Schwarz

17:15 – 17:45  Biologics for Psoriasis and other diseases – IL-23
Melinda Gooderham

17:45 – 18:15  JAKis for AD and other diseases
Melinda Gooderham

18:15 – 18:20  Closing
Eung Ho Choi

Symposium for Platinum Sponsor

Maruho Symposium
Title: The Birth of a Novel Treatment for Itching with IL-31RA Antibody 
Room: Room B (Eminence Hall) – 5F (south tower)

PROGRAM:

Importance of IL-31 signaling in pruritic skin diseases      
Chair: Kenji Kabashima
Speaker: Bernhard Homey

Characterization of sensory nerves transmitting itch during skin barrier impairment and inflammation
Chair: Lisa A. Beck
Speaker: Takaharu Okada

Understanding the role of IL31 as a target for atopic dermatitis」
Chair: Norito Katoh
Speaker: Gil Yosipovitch

Rooms: Room C (Nishiki), Room D (Ohgi) Room B (Eminence Hall) and their lobbies

The Opening Ceremony & Welcome Reception will take place on Pre Congress Day at the Keio Plaza Hotel, in the“Concord” room. Being held at the main venue, it will be a convenient location for all attendees, and will be a great occasion to reunite with colleagues and peers. Light refreshments will be served.

Thursday 11 May 2023

Day Two

Symposium for Silver Sponsor
Japan Blood Products Organization Symposium

Title: Dermatomyositis
Room: Room A (Concord Ballroom) – 5F  (main tower)
Boxed breakfast provided

PROGRAM:
Chair: Manabu Fujimoto

Single cell analysis and the role of cytokines in dermatomyositis
Victoria P. Werth

Novel autoantigens in cancer associated dermatomyositis
David Fiorentino

Symposium for Silver Sponsor
Otsuka Pharmaceutical Symposium

Title: Pathophysiology of Atopic Dermatitis
Room: Room B (Eminence Hall) – 5F (south tower)
Boxed breakfast provided

PROGRAM:
Chairs: Takeshi Nakahara, Hiroyuki Murota

PDE4 inhibition by difamilast regulates filaggrin and loricrin expression via keratinocyte proline-rich protein in human keratinocytes.     
Gaku Tsuji

Basophils in the pathogenesis of atopic dermatitis    
Hajime Karasuyama

Symposium for Silver Sponsor
Kaken Pharmaceutical Symposium

Title: New Findings on Terbinafine-resistant Dermatophytosis – Epidemiology, resistance mechanisms, and prevention methods.
Room: Room C (Nishiki) – 4F (south tower)
Boxed breakfast provided

PROGRAM:
Chair: Kazutoshi Harada

New findings on terbinafine-resistant dermatophytosis: Epidemiology, resistance mechanisms, and prevention methods
Rui Kano

Symposium for Silver Sponsor
Taisho Pharmaceutical Symposium

Title:  Visualization of vascular network in the skin and brain enables the understanding of stem cell niche -Cross-talk system between “vasculature” and “hair cycle/minoxidil/skin homeostasis”
Room: Room D (Ohgi) 4F (south tower)
Boxed breakfast provided

PROGRAM:

Visualization of vascular network in the skin and brain enables the understanding of stem cell niche -Cross-talk system between “vasculature” and “hair cycle/minoxidil/skin homeostasis”

Chair: Manabu Ohyama
Speaker: Ken-ichi Mizutani

Symposium for Silver Sponsor
AMRYT Symposium

Title: Epidermolysis Bullosa – Concepts for Change
Room: Room F (Harmony) – 44F (main tower)
Boxed breakfast provided

PROGRAM:
Faculty: John McGrath, Dedee Murrell, Mauricio Torres-Pradilla

07:00 Opening Remarks – The Complexity of EB
John McGrath

07:05 EB Wounds – A Fundamental Priority
Mauricio Torres

07:10 Approaching a New Era for Patients with EB
John McGrath

07:20 Defining and Measuring Patient Outcomes
Dedee Murrell

07:35 Translating Clinical Studies into Clinical Practice
Mauricio Torres

07:45 Panel Discussion and Audience Questions, Closing Remarks
John McGrath

Room: Room A (Concord Ballroom)
Chairs: Kenji Kabashima, Rhoda Alani, Marta Szell

08.10-08.22           ORAL 001 [POSTER 1497]
Type 2-mediated oxidative reprogramming promotes the transition of macrophages into repair mode and is required for wound healing
S. Willenborg1, D. E. Sanin2, E. J. Pearce2, A. Trifunovic3, H. Kashkar3, S. A. Eming1, 3
1Universitat zu Koln, Cologne, Germany, 2Johns Hopkins University, Baltimore, Maryland, United States, 3Exzellenzcluster CECAD in der Universitat zu Koln, Cologne, Germany

08.22 -08.34          ORAL 002 [POSTER 603]
Degradation of aberrant NETs by DNases is a promising therapeutic strategy for SJS/TEN
M. Kinoshita1, Y. Ogawa1, N. Hama2, A. Hasegawa2, S. Shimada1, R. Abe2, T. Kawamura1
1University of Yamanashi, Yamanashi, Japan, 2Niigata University, Niigata, Japan


08.34-08.46 
          ORAL 003 [POSTER 187]
Recurrent neural networks to predict biologic treatment outcomes in psoriasis
A. Hussain1, C. Atallah1, C. Griffiths2, 3, R. B. Warren2, 3, S. Dlay1, N. Reynolds1, 3
1Newcastle University, Newcastle upon Tyne, United Kingdom, 2Dermatology Centre, The University of Manchester, Manchester, United Kingdom, 3BADBIR study group, Manchester, United Kingdom

08.46-08.58           ORAL 004 [POSTER 180]
Immune-mesenchymal crosstalk contribute to expansion of autoreactive plasma cells in the tertiary lymphoid structures in hidradenitis suppurativa
W. Yu1, 2, J. Barrett1, J. Tong1, M. Lin1, J. C. Devlin3, 4, A. Herrera5, M. Marohn1, J. Remark1, 4, P. Liu6, J. Krueger7, K. V. Ruggles3, 8, S. B. Koralov5, E. S. Chiu1, C. Lu1, 9
1Plastic Surgery, New York University, New York, New York, United States, 2Department of Dermatology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, 3Institute of Systems Genetics, New York University Grossman School of Medicine, New York, New York, United States, 4Vilcek Institute of Graduate Biomedical Sciences, New York University Grossman School of Medicine, New York, New York, United States, 5Department of Pathology, New York University Grossman School of Medicine, New York, New York, United States, 6Department of Ophthalmology, Kaohsiung Medical University, Kaohsiung, Taiwan, 7Laboratory of Investigative Dermatology, The Rockefeller University, New York, New York, United States, 8Division of Translational Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, New York, United States, 9Department of Cell Biology, New York University Grossman School of Medicine, New York, New York, United States

08.58-09.10           ORAL 005 [POSTER 321]
A human tissue model of Darier disease reveals MEK as a novel therapeutic target downstream of SERCA2 deficiency
S. A. Zaver1, M. Sarkar2, A. Tiwaa1, J. Zou3, S. Egolf3, B. Capell3, J. Gudjonsson2, C. L. Simpson1
1Dermatology, University of Washington School of Medicine, Seattle, Washington, United States, 2Dermatology, University of Michigan, Ann Arbor, Michigan, United States, 3Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Neuroimmune mechanisms underlying atopic dermatitis itch and inflammation
Diana Bautista 

Room: Room A (Concord Ballroom)
Chair: Elena Ezhkova

Recent Progress in iPS Cell Research and Application
Shinya Yamanaka

Room: Room A (Concord Ballroom)
Chair: Masayuki Amagai 

Room: Room A (Concord Ballroom)
Chairs: Dongyoun Lee, Johann Gudjonsson and Neil Rajan

10.20-10.32           ORAL 006 [POSTER 414 ]
Identification of metagenes for prediction of therapeutic efficacy and disease monitoring by decomposing atopic dermatitis skin mRNA-seq data.
A. Fukushima-Nomura1, H. Kawasaki1, 2, K. Tanese1, E. Kawakami3, M. Amagai1
1Dermatology, Keio University School of Medicine, Tokyo, Japan, 2Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan, 3Advanced Data Science Project, RIKEN, Yokohama, Japan

10.32-10.44           ORAL 007 [POSTER 694 ]
Keratinocyte autophagy deficiency aggravates itch-related scratching in atopic dermatitis
G. Peng1, 2, W. Zhao2, K. Okumura2, H. Ogawa2, S. Ikeda1, 2, F. Niyonsaba2, 3
1Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan, 2Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan, 3Faculty of International Liberal Arts, Juntendo Daigaku, Tokyo, Japan

10.44 -10.56           ORAL 008  [POSTER 287 ]
Investigating drivers of disease progression in cutaneous squamous cell carcinoma.
M. Treanor-Taylor1, 2, L. Mcgarry1, 2, L. Carlin1, 2, C. Harwood3, I. Leigh3, P. Bailey1, 2, G. Inman1, 2
1Cancer Research UK Beatson Institute, Glasgow, United Kingdom, 2University of Glasgow, Glasgow, Scotland, United Kingdom, 3Queen Mary University of London, London, United Kingdom

10.56-11.08           ORAL 009  [POSTER 866 ]
A single nucleotide activity map of skin disease variants and transcription factors that modulate them
D. Porter, D. L. Reynolds, R. Meyers, W. Miao, A. W. Hong, X. Yang, L. Ducoli, S. Mondal, Z. Siprashvili, I. Elfaki, S. Srinivasan, P. A. Khavari
Dermatology, Stanford University, Stanford, California, United States

11.08-11.20           ORAL 010  [POSTER 1315 ]
Differential response of 3D African American and White Non-Hispanic skin organoids to major pro-inflammatory cytokines
I. Budunova1, D. Trubetskoy1, A. Klopot1, B. Shi1, L. C. Tsoi2, B. E. Perez White1
1Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States, 2Dermatology, University of Michigan, Ann Arbor, Michigan, United States

Immune-tissue crosstalk during homeostasis and disease
Keisuke (Chris) Nagao

Room: Room A (Concord Ballroom)
Chair: Shinji Shimada

Symposium for Gold Sponsor

UCB Medical Symposium
Title: Understanding Hidradenitis Suppurativa: an Educational Symposium
Room: Room A (Concord Ballroom) – 5F  (main tower)
Boxed lunch provided

PROGRAM:
Chairs: Kenji Kabashima, and Nicole Ward

Introducing HS: what does psoriatic disease tell us about the drivers of inflammation?
Stevan Shaw

Understanding HS: what have we uncovered about its complex pathophysiology?
James Krueger

Managing HS: where are we now and where do we aim to be?
Kenzo Takahashi

 

Symposium for Gold Sponsor

Taiho Pharmaceutical/Janssen Pharmaceutical K. K. Symposium
Title: Pathophysiology of Psoriasis and the Role of IL-23
Room:  Room B (Eminence Hall) – 5F (south tower)
Boxed lunch provided

PROGRAM:

Pathophysiology of Psoriasis and the Role of IL-23
Chair: Yoshihide Asano
Speaker: Tetsuya Honda

 

Symposium for Gold Sponsor

Bristol Myers Squibb Symposium
Title: A New Pathway for Psoriasis Treatment
Room: Room C (Nishiki) – 4F (south tower)
Boxed lunch provided

PROGRAM:

Chair: Akiharu Kubo
Positioning of Deucravacitinib in Psoriasis Treatment
Speaker: Yukie Yamaguchi

Chair: Ryuhei Okuyama
Differentiation of SOTYKTU from pan-JAKis – mechanisms to basic science
Speaker: Johann Gudjonsson

Symposium for Gold Sponsor

Pfizer Symposium
Title: JAK and Other Kinase Inhibitors in Dermatology: Dawn of a New Therapeutic Era
Room: Room D (Ohgi) 4F (south tower)
Boxed lunch provided

Welcome and Introductions
Melinda Gooderham

Kinase Pathways: Gateway to Understanding Immuno-Inflammatory Dermatological Diseases
Melinda Gooderham

The Therapeutic Potential of a New Drug Class: Kinase inhibitors in Dermatology
Thierry Passeron

Panel Discussion / Q&A
All

Symposium for Gold Sponsor

Sulwhasoo (Amorepacific) Symposium
Title: Skin Epigenetics
Room: Room E (Moonlight) – 
Boxed lunch provided

PROGRAM:
Chair: Jin Ho Chung

Epigenetic Landscape of Skin Aging
Sewon Kang

Advanced epigenetic regulation for skin anti-aging
Kyu-Han Kim

Symposium for Gold Sponsor

CHANEL Fragrance & Beauty Symposium
Title: Senescence: The Global Approach to Skin Aging
Room: Room F (Harmony) – 44F (main tower)
Boxed lunch provided

PROGRAM:
Chairs: Youcef Ben Khalifa and Florian Gruber

Analytic Imaging of Senescence – Induced Changes in Lipid and Carbohydrate Metabolism
Florian Gruber

Impact of Cellular Senescence in Aging Pigmentation
Hee Young Kang

Cosmetic Application: CHANEL Natural ingredients Regulating Senescence Pathways for Unmatched Anti-aging Benefits of our Products
Sandra Forestier

Symposium for Gold Sponsor

Galderma Symposium
Title: Targeting itch and beyond: IL-31, a central neuroimmune mediator in atopic dermatitis and prurigo nodularis
Room: Room G (Takao) – 42F (main tower)
Boxed lunch provided

PROGRAM:
12:05–12:08 Chair’s welcome and introduction
Lisa Beck

12:08–12:20 The torment of itch: Understanding the invisible symptom
Lisa Beck

12:20–12:35 IL-31 signaling: Neuroimmune mediation in itch, inflammation and epithelial structure
Bernhard Homey

12:35–12:50 The unique role of IL-31: Uncovering the pathophysiology of atopic dermatitis and prurigo nodularis
Lam C. (Alex) Tsoi

12:50–13:05 Panel discussion and close
All; facilitated by Prof. Lisa Beck

Adaptive and Auto-Immunity 1
Room:
Room A (Concord Ballroom) – 5F  (main tower)
Chairs: Yoshihide Asano, Jaehyuk Choi and Kilian Eyerich

13.15 -13.25           ORAL 011  [POSTER 120]
Identification of post-translationally modified trichohyalin epitopes responsible for triggering autoimmunity in alopecia areata
S. D. Jadeja, D. Tobin
Charles Institute of Dermatology, University College Dublin, Dublin, Ireland

13.25-13.35           ORAL 012   [POSTER 074]
Newly identification of a CXCR6pathogenic skin-resident CD4+ T cell subset in a mouse model of allergic dermatitis that requires CXCL16 for its maintenance
R. Asahina, F. Minami, G. Egawa, S. Nakamizo, K. Kabashima
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan

13.35-13.45           ORAL 013    [POSTER 028]
Psychological stress exacerbates IgE-dependent chronic allergic inflammation by suppressing efferocytosis of M2 macrophages

H. Urakami1, Y. Fujita2, K. Nagao2, K. Miyake4, H. Karasuyama4, S. Miyake3, A. Kamiya2, S. Yoshikawa3, S. Morizane1
1Department of Dermatology, Okayama Daigaku Daigakuin Ishiyakugaku Sogo Kenkyuka, Okayama, Okayama, Japan, 2Department of Cellular Physiology, Okayama Daigaku Daigakuin Ishiyakugaku Sogo Kenkyuka, Okayama, Okayama, Japan, 3Department of Immunology, Juntendo Daigaku Igakubu Daigakuin Igaku Kenkyuka, Bunkyo-ku, Tokyo, Japan, 4Inflammation, infection and Immunity Laboratory, Advanced Research Institute, Tokyo Ika Shika Daigaku, Bunkyo-ku, Tokyo, Japan

13.45-13.55           ORAL 014    [POSTER 227]
Immune response and allergenic components of COVID-19 vaccines induced delayed cutaneous reactions

C. Tsai, W. Chung, C. Chen
Drug Hypersensitivity Clinical and Research Center, Department of Dermatology,, Chang Gung Memorial Hospital, Linkou, Taipei, Tucheng and Keelung, Taiwan, Taoyuan, Taiwan

13.55-14.05           ORAL 015    [POSTER 126]
Topical corticosteroids inhibit allergic skin inflammation but are ineffective in impeding the formation and expansion of resident memory T cells
E. Ono1, V. Lenief1, M. Lefevre1, R. Cuzin1, A. Guironnet-Paquet1, A. Mosnier1, A. Nosbaum1, 2, J. Nicolas1, 2, M. Vocanson1
1Centre International de Recherche en Infectiologie, Lyon, Rhône-Alpes, France, 2Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes , France

14.05-14.15           ORAL 016    [POSTER 001]
Staphylococcus aureus skin colonization promotes SLE-like autoimmune inflammation via neutrophil activation and the IL-23/IL-17 axis
H. Terui1, K. Yamasaki1, M. Wada-Irimada1, M. Onodera-Amagai1, N. Hatchome1, M. Mizuashi1, R. Yamashita2, T. Kawabe3, N. Ishii3, T. Abe4, 5, 6, Y. Asano1, S. Aiba1
1Department of Dermatology, Tohoku Daigaku Daigakuin Igakukei Kenkyuka Igakubu, Sendai, Miyagi, Japan, 2Division of Translational Informatics, Kokuritsu Gan Kenkyu Center Sentan Iryo Kaihatsu Center Kashiwa Campus, Kashiwa, Chiba, Japan, 3Department of Microbiology and Immunology, Tohoku Daigaku Daigakuin Igakukei Kenkyuka Igakubu, Sendai, Miyagi, Japan, 4Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku Daigaku Daigakuin Igakukei Kenkyuka Igakubu, Sendai, Miyagi, Japan, 5Division of Medical Science, Tohoku Daigaku Daigakuin Ikogaku Kenkyuka, Sendai, Miyagi, Japan, 6Department of Clinical Biology and Hormonal Regulation, Tohoku Daigaku Daigakuin Igakukei Kenkyuka Igakubu, Sendai, Miyagi, Japan

14.15-14.25          ORAL 017   [POSTER 140]
Comparative scRNA-Seq profiling of four autoimmune skin diseases points to CXCL13 as a potential player in skin autoimmunity
Y. Wang, K. Afshari, M. Frisoli, N. Haddadi, S. Sherman, J. E. Harris, M. Rashighi, M. Garber
University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States

14.25-14.35           ORAL 018    [POSTER 133]
UVB-induced type-I interferon in keratinocytes is associated with expansion of CXCL13+ skin-resident memory T cells in dermatomyositis skin

K. Afshari1, Y. Wang1, N. Haddadi1, S. Sherman1, J. Richmond1, R. Vleugels2, M. Garber1, M. Rashighi1
1University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States, 2Harvard Medical School, Boston, Massachusetts, United States

14.35-14.45           ORAL 019   [POSTER 054]
LPCAT1 aggravates hyperproliferation and inflammatory signals in psoriasis

Y. Huang1, Y. Wang2, Y. Wang3, Y. Zhen1, Q. Sun1
1Department of Dermatology, Qilu Hospital of Shandong University, Jinan, Shandong, China, 2Department of Dermatology, Xi’an Jiaotong University, Xi’an, Shaanxi, China, 3School of Life Science and Technology, Xi’an Jiaotong University, Xi’an, Shaanxi, China

14.45-14.55           ORAL 020   [POSTER 147]
Sebaceous glands actively contribute to distinct immune response patterns in atopic dermatitis and psoriasis

P. Seiringer7, 4, 1, C. Hillig2, T. Biedermann7, C. C. Zouboulis6, M. Menden2, K. Eyerich3, 1, D. Töröcsik5
1Division of Dermatology and Venerology, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden, 2Institute of Computational Biology, Helmholtz Zentrum München, Neuherberg, Germany, 3Albert-Ludwigs-Universitat Freiburg, Freiburg, Germany, 4Zentrum Allergie und Umwelt, Munich, Germany, 5Department of Dermatology, Faculty of Medicine, Debreceni Egyetem, Debrecen, Hungary, 6Medizinische Hochschule Brandenburg Theodor Fontane, Neuruppin, Germany, 7Klinikum rechts der Isar, Department of Dermatology and Allergy, Technische Universitat Munchen, Munchen, Germany

14.55-15.05           ORAL 021    [POSTER 076]
TRPM2-dependent autophagy inhibition promotes CXCL16 secretion by keratinocytes under oxidative stress

P. Kang, Y. Wang, J. Chen, S. Li, X. Yi, C. Li
Department of Dermatology, Xijing Hospital, Air Force Medical University, Xi’an, Shaanxi, China

15.05-15.15           ORAL 022    [POSTER 172]
Spatiotemporal architecting of skin dendritic cell directed immunity and tolerance

Q. Huang1, A. S. Doane2, Y. Liu2, J. Valencia5, C. Nirschl6, J. Hsu2, A. Savitz1, K. Pradhan1, A. Jaiswal2, G. Song-Zhao6, M. Bale2, R. R. Ricardo-Gonzalez4, R. Locksley4, T. Lawrence7, H. Young5, M. Suarez-Farinas3, O. Elemento2, N. Anandasabapathy1
1Department of Dermatology, Weill Cornell Medicine, New York, New York, United States, 2Weill Cornell Medicine, New York, New York, United States, 3Icahn School of Medicine at Mount Sinai, New York, New York, United States, 4University of California San Francisco, San Francisco, California, United States, 5National Cancer Institute, Bethesda, Maryland, United States, 6Harvard Medical School, Boston, Massachusetts, United States, 7King’s College London, London, United Kingdom

15.15-15.25           ORAL 023    [POSTER 008]
Characterization and pharmacological inhibition of an adult antibody-transfer mouse model of pemphigus vulgaris

S. Emtenani1, M. Hofrichter1, L. Komorowski2, C. Probst2, S. Patzelt1, E. Schmidt1, 3
1Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany, 2Institute of Experimental Immunology, EUROIMMUN AG, Lübeck, Germany, 3Department of Dermatology, University of Lübeck, Lübeck, Germany

15.25-15.35           ORAL 024    [POSTER 012]
CD4+ T cells control immune evasive tumors by reprogramming myeloid cells in an IFN-dependent manner

A. Buzzai1, B. Kruse1, N. Shridhar1, A. Braun1, S. Gellert1, K. Knauth1, J. Peters1, M. Mengoni1, T. van der Sluis1, A. Krone1, D. Yu2, S. Höhn1, Y. Fu1, M. Essand2, R. Geffers3, D. Mougiakakos1, S. Kahlfuß1, H. Kashkar4, E. Gaffal1, W. Kastenmüller5, A. Müller1, T. Tüting1
1Otto-von-Guericke-Universitat Magdeburg Medizinische Fakultat, Magdeburg, Germany, 2Uppsala Universitet, Uppsala, Sweden, 3Helmholtz-Zentrum fur Infektionsforschung GmbH, Braunschweig, Niedersachsen, Germany, 4Institute of Molecular Immunology, Köln, Germany, 5Institute for Systems Immunology, Würzburg, Germany

15.35-15.45           ORAL 025    [POSTER 154]
Nociceptor sensory neurons promote CD8 T cell response to VACV infection

J. Zhang1, T. Pan1, A. Kley1, J. B. Williams1, L. Deng2, I. Chiu2, T. S. Kupper1
1Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts, United States, 2Immunology, Harvard Medical School, Boston, Massachusetts, United States

Artificial Intelligence (AI) and Translational Studies
Room:
Room B (Eminence Hall) – 5F (south tower)
Chairs:
Takashi Okamoto, Shawn Kwatra, Thomas Tüting

13.15-13.25           ORAL 026    [POSTER 217]
Time-to-event machine learning prediction of metastatic recurrence of localized melanoma
G. Wan1, 5, B. Leung1, M. DeSimone2, N. Nguyen1, A. Rajeh1, M. Collier1, H. Rashdan1, K. Roster1, M. Asgari1, 5, A. Gusev3, A. Stagner1, C. Lian2, M. Hurlbert4, K. Yu5, H. Tsao1, 5, F. Liu6, P. Sorger5Y. Semenov1, 5
1Massachusetts General Hospital, Boston, Massachusetts, United States, 2Brigham and Women’s Hospital, Boston, Massachusetts, United States, 3Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 4Melanoma Research Alliance, Washington, District of Columbia, United States, 5Harvard Medical School, Boston, Massachusetts, United States, 6Stevens Institute of Technology, Hoboken, New Jersey, United States

13.25-13.35           ORAL 027    [POSTER 202]
 Automated assessment of tumor infiltrating lymphocytes informs mortality in thin melanoma
S. X. Tan1, T. Nwe Aung2, M. Claeson3, C. Zhou1, S. Brown1, B. Acs2, D. Lambie6, P. Baade4, N. Pandeya5, H. Soyer1, B. Smithers6, D. Whiteman5, D. Rimm2, K. Khosrotehrani1
1The University of Queensland, Saint Lucia, Queensland, Australia, 2Yale University, New Haven, Connecticut, United States, 3Sahlgrenska Academy, Gothenburg, Sweden, 4Cancer Council Queensland, Spring Hill, Queensland, Australia, 5QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia, 6Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

13.35-13.45           ORAL 028    [POSTER 203]
Automated skin surface phenotype for melanoma risk assessment
B. D. Betz-Stablein1, C. Rutjes1, S. Kahler1, A. Mothershaw1, D. Jayasinghe2, M. Stark1, M. Janda2, H. Soyer1
1Dermatology Research Centre, The University of Queensland, Brisbane, Queensland, Australia, 2Centre for Health Services Research, The University of Queensland, Brisbane, Queensland, Australia

13.45-13.55           ORAL 029    [POSTER 212]
Teledermatology photographs deblurring by deep learning models restores the accuracy of blurry images classification
Z. Jiang3, H. Yeh1, B. Hsu2, S. Chou2, T. Hsu3, V. S. Tseng2, C. Lee3, 4
1Chen Chia-Wei Dermatology, Kaohsiung, Taiwan, 2Computer Science, National Yang Ming Chiao Tung University, Hsinchu, Taiwan, 3Dermatology, Chang Gung Memorial Hospital Kaohsiung Branch, Kaohsiung, Taiwan, 4Chang Gung University College of Medicine, Taoyuan, Taiwan

13.55-14.05           ORAL 030    [POSTER 207]
Comparison of neural network classification models to determine patch test reactivity
A. Ravishankar, P. L. Bigliardi
Dermatology, University of Minnesota Twin Cities, Minneapolis, Minnesota, United States

14.05-14.15           ORAL 031    [POSTER 210]
A novel system with an end-to-end framework for mouse scratching detection based on deep learning techniques
J. P. Peng1, B. Hsu2, Y. Lin2, V. S. Tseng2, C. Lee3
1Chang Gung Memorial Hospital Kaohsiung Branch Department of Internal Medicine, Kaohsiung, Taiwan, 2National Yang Ming Chiao Tung University Department of Computer Science, Hsinchu, Taiwan, 3Department of Dermatology, Chang Gung Memorial Hospital Kaohsiung Branch, Kaohsiung, Taiwan

14.15-14.25           ORAL 032    [POSTER 214]
Transforming wound assessment and management with artificial intelligence
P. Bishnoi1, Y. Ng1, O. E. Ping2, R. Srivastava2, T. K. Kyar2, D. Y. Tan3, Z. Jingxian3, H. Susainathan3, R. Q. So2
1Skin Research Institute of Singapore, A*STAR, Singapore, Singapore, 2Institute for Infocomm Research, Singapore, Singapore, 3Diagnostics Development Hub, Singapore, Singapore

14.25-14.35           ORAL 033    [POSTER 1572]
HLA I shields tumor lymphocytes from NK-cell-mediated elimination in the skin
Y. Chang1, S. Kimeswenger2, M. Bobrowicz4, S. Pascolo3, W. Hoetzenecker2, E. Guenova1
1Dermatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Vaud, Switzerland, 2Dermatology, Johannes Kepler Universitat Linz, Linz, Austria, 3Dermatology, UniversitatsSpital Zurich, Zurich, Switzerland, 4Immunology, Warszawski Uniwersytet Medyczny, Warszawa, Mazowieckie, Poland

14.35-14.45           ORAL 034    [POSTER 1625]
Novel mechanism of cell proliferation in cutaneous T cell lymphoma
X. Zhang, H. Li, C. Chen, J. Hsiang, S. Nam, W. Hu, X. Wu, D. Horne, J. Shively, S. Rosen
City of Hope, Duarte, California, United States

14.45 PM-14.55           ORAL 035    [POSTER 1545]
Circulating tumor DNA reflects tumor burden and detects early recurrence in patients with Merkel cell carcinoma
T. Akaike1, D. S. Hippe2, N. So3, N. Maloney3, L. Gunnell1, E. Hall1, A. Rodriguez4, A. Aleshin4, P. Nghiem1, L. Zaba3
1University of Washington, Seattle, Washington, United States, 2Fred Hutchinson Cancer Research Center, Seattle, Washington, United States, 3Stanford University School of Medicine, Stanford, California, United States, 4Natera, Inc, Austin, Texas, United States

14.55-15.05           ORAL 036    [POSTER 1556]
CSL324, a G-CSF receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa
C. Gamell1, K. Scalzo-Inguanti1, B. Sedgmen1, M. Alhamdoosh1, C. Millar1, L. Johnson1, A. Dyson1, J. Nicolopoulos2, G. Varigos2, M. Ng1, N. Wilson1, J. Field1, J. S. Kern2L. M. Lindqvist1
1CSL Limited, Parkville, Victoria, Australia, 2The Royal Melbourne Hospital, Parkville, Victoria, Australia

15.05-15.15           ORAL 037    [POSTER 1621]
Spatial mass cytometry-based single cell imaging reveals a disrupted epithelial-immune axis in prurigo nodularis
A. Kambala, J. R. Patel, H. Cornman, K. K. Lee, S. V. Reddy, O. O. Oladipo, W. Ho, S. Kwatra
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

15.15-15.25           ORAL 038    [POSTER 1607]
Multiomic analysis of immune-related adverse events (irAEs) in melanoma patients treated with anti-PD1-based immune checkpoint inhibitors (ICIs)
F. Dimitriou1, P. Cheng1, A. Saltari1, R. Staeger1, A. Tastanova1, M. Levesque1, G. Long3, B. Becher2, R. Dummer1
1Dermatology Department, UniversitatsSpital Zurich, Zurich, Switzerland, 2Immunology Department, Universitat Zurich, Zurich, Switzerland, 3Melanoma Institute Australia, North Sydney, New South Wales, Australia

15.25-15.35           ORAL 039    [POSTER 1598 ]
Comparative proteomic analyses of microdissected nevi and melanoma subtypes reveal functional differences
S. Naimy2, 3, D. Kuczek4J. B. Solberg1, M. Bzorek2, T. Litman5, A. Mund3, M. B. Lovendorf1, 5, R. Clark6, L. R. Gjerdrum2, 7, M. Mann3, 4, B. Dyring-Andersen1, 3, 5
1Department of Dermatology and Allergy, Herlev-Gentofte University Hospital, Hellerup, Denmark, 2Department of Pathology, Copenhagen University Hospital, Zealand University Hospital, Roskilde, Denmark, 3Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark, 4Max-Planck-Institute of Biochemistry, Munich, Martinsried, Germany, 5Leo Foundation Skin immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark, 6Department of Dermatology, Brigham’s and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States, 7Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

15.35-15.45           ORAL 040    [POSTER 1566 ]
Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor co-stimulatory domains
C. Berry1, C. Lee1, A. R. Kelly2, S. Oh1, R. O’Connor2, C. Ellebrecht1
1Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, United States, 2Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Carcinogenesis and Cancer Genetics
Room:
Room C (Nishiki) – 4F (south tower)
Chairs: Kiarash Khosrotehrani, Kavita Sarin and Remco van Doorn

13.15-13.25          ORAL 041    [POSTER 264 ]
Genetic ablation of host p38δ promotes antitumor immunity and reduces tumor growth
A. Kiss1, J. Chen1, F. Cheng1, C. Wei1, N. Adusumilli1, S. Sandhu1, S. Simmens1, E. Sotomayor3T. Efimova2, 1
1
The George Washington University, Washington, District of Columbia, United States, 2Northwestern University, Evanston, Illinois, United States, 3Tampa General Hospital, Tampa, Florida, United States

13.25-13.35           ORAL 042    [POSTER 277]
HPV8 E6 induced STAT3 activation leads to hair follicle junctional zone keratinocyte stem cell proliferation and expansion in actinic keratoses
C. Olivero1, H. Morgan1, L. Martuscelli2, A. Gibbs1, B. Shorning1, C. Borgogna2, M. De Andrea2, M. Hufbauer3, S. Smola4, H. Pfister3, B. Akgul3, M. Gariglio2G. Patel1
1European Cancer Stem Cell Research Institute, Cardiff University, Cardiff, United Kingdom, 2Translational Medicine, University of Piemonte Orientale, Novara, Italy, 3Virology, Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany, 4Virology, Saarland University Medical Center, Homburg, Germany

13.35-13.45           ORAL 043    [POSTER 297]
Expanded genomic landscape of merkel cell carcinoma identifies new drivers
Y. Zhang1, Z. Reinstein1, K. Qiu1, J. Jackson1, M. Nichols2, H. Liu1, K. Tsai2, J. Choi1
1Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States, 2Department of Pathology, Moffitt Cancer Center, Tampa, Florida, United States

13.45-13.55           ORAL 044    [POSTER 267]
Establishment of a new immunocompetent mouse model of merkel cell carcinoma
K. M. Prieto-Sarmiento1, A. de Mingo Pulido1, B. R. Sell1, O. Chavez Chiang1, P. W. Harms2, M. E. Verhaegen2, A. Dlugosz2, T. Patel3, C. Coarfa3, K. Tsai1
1Clinical Science, Moffitt Cancer Center, Tampa, Florida, United States, 2Dermatology, University of Michigan, Ann Arbor, Michigan, United States, 3Baylor College of Medicine, Houston, Texas, United States

13.55-14.05           ORAL 045    [POSTER 311]
Single-cell transcriptomics reveals distinct molecular programs in folliculotropic mycosis fungoides
T. Qin1, A. Billi2, J. Runge2, R. Wasikowski2, Q. Li2, Y. Wang3, M. Sartor2, P. W. Harms2, J. Gudjonsson2, A. Hristov2, L. C. Tsoi2, T. Tejasvi12
1Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, United States, 2University of Michigan, Ann Arbor, Michigan, United States, 3Peking University, Beijing, China

14.05-14.15           ORAL 046    [POSTER 303 ]
Single-cell RNA sequencing of erythrodermic CTCL compared to atopic dermatitis and unspecific chronic erythroderma defines disease-specific markers
K. Rindler1, S. Chennareddy2, M. Medjimorec1, L. Shaw1, U. Mann1, W. Weninger1, M. Farlik1, C. Jonak1, P. Brunner2
1Department of Dermatology, Medizinische Universitat Wien, Wien, Wien, Austria, 2Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, United States

14.15-14.25           ORAL 047    [POSTER 253 ]
PRMT1 inhibition as a novel therapeutic approach in squamous cell carcinoma
R. Boudra1, B. Patenall1, S. King1, S. Xu2, D. Wang2, M. Padilla1, C. Schmults1, S. Barthel1, C. Lian2M. R. Ramsey1
1Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts, United States, 2Pathology, Brigham and Women’s Hospital, Boston, Massachusetts, United States

14.25-14.35           ORAL 048    [POSTER 244 ]
The sphingosine-1-phosphate-cathelicidin axis has a pivotal role in the development of cutaneous squamous cell carcinoma
K. Park1, 2, 3, Y. Kim2, 3, K. Shin1, 4, Y. Bae1, Y. Choi1, A. Nielsen-Scott2, 3, C. Mainzer2, 3, A. Celli2, 3, W. Holleran2, 3, S. Arron2, 3, T. Mauro2, 3, P. Elias2, 3Y. Uchida1, 2, 3
1Food Science and Nutrition, Hallym University, Chuncheon, Gangwon-do, Korea (the Republic of), 2Dermatology, University of California San Francisco, San Francisco, California, United States, 3Northern California Institute for Research and Education, San Francisco, California, United States, 4LaSS Inc., Chunche, Korea (the Republic of)

14.35-14.45           ORAL 049    [POSTER 258 ]
Ire1α nmsc mutations enhance keratinocyte uv response and survival through rac1 activation
S. Mogre, J. Son, A. Glick
The Pennsylvania State University, University Park, Pennsylvania, United States

14.45-14.55           ORAL 050    [POSTER 250 ]
A specific neurotrophin network characterizes cSCC subpopulations and correlates with their behavior by patient-derived spheroids and zebrafish avatar
M. Quadri1, L. Reggiani Bonetti2, R. Panini2, N. Tiso3, R. Lotti1, C. Pincelli1, A. Marconi1E. Palazzo1
1CHIMOMO, Unimore, Modena, Italy, 2Dept of Pathology, Unimore, Modena, Italy, 3Dept of Biology, UniPD, Padua, Italy

14.5-15.05           ORAL 051    [POSTER 275 ]
Spatial transcriptomics of early invasive melanomas reveals molecular determinants of patient survival
C. Zhou1, S. X. Tan1, Y. Kao1, M. Claeson5, S. Brown1, D. Lambie3, D. Whiteman2, H. Soyer1, M. Stark1, Q. Nguyen4, K. Khosrotehrani1
1The University of Queensland Frazer Institute, Brisbane, Queensland, Australia, 2QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia, 3Pathology Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia, 4The University of Queensland Institute for Molecular Bioscience, Saint Lucia, Queensland, Australia, 5Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

15.05-15.15           ORAL 052    [POSTER 289 ]
Crosstalk between MET-dependent receptor tyrosine kinase signaling and oncogenic Gαq mutations in melanoma
B. Andreas1, M. Mengoni1, S. Seedarala1, S. Bonifatius1, E. Kostenis2, T. Tüting1E. Gaffal1
1Dermatology, University Hospital Magdeburg, Magdeburg, Germany, 2University of Bonn, Bonn, Germany

15.15-15.25           ORAL 053    [POSTER 233 ]
Epigenetic age dysregulation is associated with clinical features of cutaneous melanoma and melanocytic nevi
R. Jeremian1, 2, J. R. Georgakopoulos3, 4, J. Yeung4, 3, I. Litvinov2, 1
1McGill University Faculty of Medicine and Health Sciences, Montreal, Quebec, Canada, 2McGill University Health Centre, Montreal, Quebec, Canada, 3University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada, 4Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

15.25-15.35           ORAL 054    [POSTER 305 ]
Matrix metalloproteinase-1 expression in fibroblasts accelerates dermal aging and promotes tumor development in mouse skin
G. J. Fisher1, W. Xia1, T. He1, G. Bou-Gharios2, J. J. Voorhees1, A. Dlugosz1, T. Quan1
1Dermatology, University of Michigan, Ann Arbor, Michigan, United States, 2Matrix Biology, University of Liverpool Faculty of Health and Life Sciences, Liverpool, United Kingdom

15.35-15.45           ORAL 055    [POSTER 316 ]
EPHB2 germline mutation in patients with high frequency basal cell carcinomas and prostate carcinoma
A. Chiang1, G. Swaminathan1, M. Harris1, V. Hua1, W. Chan1, J. Ramos1, K. Yekrang1, H. Do1, I. Bailey1, K. E. Rieger1, 2, C. Curtis3, 4, J. Y. Tang1, A. Oro1, K. Sarin1
1Dermatology, Stanford University School of Medicine, Stanford, California, United States, 2Dermatopathology, Stanford University School of Medicine, Stanford, California, United States, 3Medicine (Oncology), Stanford University School of Medicine, Stanford, California, United States, 4Genetics, Stanford University School of Medicine, Stanford, California, United States

Clinical Research:  Epidemiology and Observational Research
Room:
Room D (Ohgi) 4F (south tower)
Chairs: Chong Hyun Won, Julie Ryan Wolf, Sara Brown

13.15-13.25           ORAL 056    [POSTER 448 ]
A framework to study the epidemiological and molecular basis of psoriasis severity, with application in UK Biobank and BSTOP
J. Saklatvala1, R. Ramessur1, M. Simpson1, S. M. Langan3, S. Brown4, L. Paternoster2, N. Dand1, C. Smith1
1King’s College London, London, United Kingdom, 2University of Bristol, Bristol, United Kingdom, 3London School of Hygiene & Tropical Medicine, London, United Kingdom, 4University of Edinburgh, Edinburgh, United Kingdom

13.25-13.35           ORAL 057    [POSTER 446 ]
The risk of lymphoproliferative disorders and skin cancers in patients with psoriasis and inflammatory bowel disease administered biologics
J. Jung, E. Choi, G. Kim, S. Chang, M. Lee, C. Won, W. Lee
Dermatology, Asan Medical Center, Songpa-gu, Seoul, Korea (the Republic of)

13.35-13.45           ORAL 058    [POSTER 407 ]
A population-based cohort study of sodium consumption and psoriasis
A. Chattopadhyay, B. Chiang, Y. Halezeroglu, K. Abuabara
University of California San Francisco, San Francisco, California, United States

13.45-13.55           ORAL 059    [POSTER 394 ]
Differential associations of psoriasis subtypes with autoimmune disorders in United States children and adults: A cross-sectional study
Z. Ren1, J. Silverberg2
1Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States, 2Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States

13.55-14.05           ORAL 060    [POSTER 552 ]
Transitions in blood immune profile in atopic dermatitis from infancy to adulthood
E. Del Duca1, Y. Renert-Yuval2, A. Pavel1, D. Mikhaylov1, R. Lefferdink1, M. Fang1, A. Sheth3, P. Facheris1, J. Wu1, Y. Estrada1, S. Rangel3, J. Krueger2, A. Paller3, E. Guttman-Yassky1
1Icahn School of Medicine at Mount Sinai, New York, New York, United States, 2Dermatology, The Rockefeller University, New York, New York, United States, 3Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

14.05-14.15           ORAL 061    [POSTER 383  ]
Non-invasively collected RNA in sebum reflects the characteristics and severity of atopic dermatitis.
A. Tanaka1, T. Nakahara2, K. Masuda3, N. Takada4, T. Kuwano4, T. Inoue4, S. Hoashi5, Y. Kawasaki5, H. Saeki6
1Department of Dermatology, Hiroshima Daigaku, Hiroshima, Hiroshima, Japan, 2Department of Dermatology, Kyushu Daigaku, Fukuoka, Fukuoka, Japan, 3Department of Dermatology, Kyoto Furitsu Ika Daigaku, Kyoto, Kyoto, Japan, 4Biological Science Laboratory, Kao Kabushiki Kaisha, Chuo, Tokyo, Japan, 5Diagnostics Department, Maruho Kabushiki Kaisha, Osaka, Osaka, Japan, 6Department of Dermatology, Nihon Ika Daigaku, Bunkyo, Tokyo, Japan

14.15-14.25           ORAL 062    [POSTER 540  ]
A longitudinal cohort study of atopic dermatitis and epigenetic age acceleration across childhood
M. Ye1, P. Collender2, S. M. Langan3, A. Cardenas4K. Abuabara1, 2
1UCSF, San Francisco, California, United States, 2UC Berkeley, Berkeley, California, United States, 3LSHTM, London, United Kingdom, 4Stanford University, Stanford, California, United States

14.25-14.35           ORAL 063    [POSTER 558 ]
Higher hemoglobin A1C is associated with greater disease severity in hidradenitis suppurativa
N. Foolad1, W. Liu1, 2, J. T. Kwock1, T. Jaleel1
1Dermatology, Duke University School of Medicine, Durham, North Carolina, United States, 2Department of Neurobiology, Duke University School of Medicine, Durham, North Carolina, United States

14.35-14.45           ORAL 064    [POSTER 489 ]
Long-term oral antibiotics for acne and antibiotic treatment failure
K. Bhate1, R. Mathur2, S. M. Langan1
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 2Queen Mary University of London, London, United Kingdom

14.45-14.55           ORAL 065    [POSTER 470 ]
Regulatory T cells act either by expansion at the acute phase or by steep contraction at the resolution phase in severe drug eruptions
Y. Mizukawa, R. Takahashi, T. Shiohara
Kyorin Daigaku, Mitaka, Tokyo, Japan

14.55-15.05           ORAL 066    [POSTER 562 ]
Merkel polyomavirus antibody testing for detecting recurrent Merkel cell carcinoma: A prospective, real-world outcomes study
L. Gunnell1, T. Akaike1, K. Lachance1, D. S. Hippe2, K. Cahill1, C. Doolittle-Amieva2, 1, L. Zawacki1, S. Park1, 2, P. Nghiem1, 2
1University of Washington Department of Medicine, Seattle, Washington, United States, 2Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

15.05-15.15           ORAL 067    [POSTER 385 ]
Skin cancers in patients with actinic keratoses
C. Mohr1, Y. Li1, L. Navsaria1, C. Hinkston1, D. Margolis2, M. Wehner1
1Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States, 2University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States

15.15-15.25           ORAL 068    [POSTER 450 ]
The impact of mental health comorbidities on patient satisfaction: A population study among U.S. adults with skin cancer
C. Read2, 1, 3, J. F. Apperley2, S. P. Hettiaratchy2, A. Armstrong1
1Dermatology, University of Southern California, Los Angeles, California, United States, 2Medicine, Imperial College London, London, United Kingdom, 3Dermatology, University of Washington, Seattle, Washington, United States

15.25-15.35           ORAL 069    [POSTER 541 ]
Gene set enrichment analysis identifies biological networks associated with skin aging in a large Japanese population: Data from the Nagahama cohort
J. Latreille3, G. Thorn1, 2, R. Jdid3, G. Gendronneau3, Y. Tabara4, Y. Harada5, S. Forestier3, C. Chelala1, 2, F. Matsuda4
1Bioinformatics Unit, Barts Cancer Institute, London, United Kingdom, 2Queen Mary University of London, London, United Kingdom, 3IRD, Chanel SAS, PANTIN, Île-de-France, France, 4Center for Genomic Medicine, Kyoto Daigaku Igaku Kenkyuka Fuzoku Genome Igaku Center, Kyoto, Japan, 5Research and Technology Development Laboratory, Chanel Kabushiki Kaisha Funabashi Corporate Operations Center, Funabashi, Chiba, Japan

15.35-15.45           ORAL 070    [POSTER 421 ]
Genotype-phenotype correlation analysis in Japanese patients with pachydermoperiostosis
R. Tanaka1, H. Niizeki1, T. Nomura2, A. Seki3, S. Narumi4, K. Nakabayashi5, K. Yoshida1
1Dermatology, National Center for Child Health and Development, Tokyo, Japan, 2Dermatology, Kyoto University, Kyoto, Japan, 3Orthopaedic Surgery, National Center for Child Health and Development, Tokyo, Japan, 4Molecular Endocrinology, National Center for Child Health and Development, Tokyo, Setagaya-ku, Japan, 5Maternal-Fetal Biology, National Center for Child Health and Development, Tokyo, Japan

Genetic Diseases
Room:
Room E (Moonlight) – 43F (main tower)
Chairs: Akiharu Kubo, Cristina de Guzman Strong, Edel O’Toole

13.15-13.25           ORAL 071    [POSTER 806 ]
Results from VIITAL: A phase 3, randomized, intrapatient-controlled trial of an investigational collagen type VII gene–corrected autologous cell therapy, EB-101, for the treatment of recessive dystrophic epidermolysis bullosa (RDEB)
J. Y. Tang2, M. P. Marinkovich2, 3, K. Wiss4, D. McCarthy5, A. Truesdale1, A. S. Chiou2, J. K. McIntyre4, A. Moore1, I. Grachev1
1Abeona Therapeutics Inc, Cleveland, Ohio, United States, 2Stanford University School of Medicine, Stanford, California, United States, 3VA Palo Alto Health Care System, Palo Alto, California, United States, 4University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States, 5Abeona Therapeutics Inc, Cleveland, Ohio, United States

13.25-13.35           ORAL 072    [POSTER 853 ]
HMCN1 variants aggravate epidermolysis bullosa phenotype
S. Bergson1, 2, O. Sarig1, A. Nitzan2, S. Hainzl3, T. Kocher3, M. Giladi1, 2, J. Illmer3, J. Mohamad1, 2, E. Geller1, 2, K. Malovitski1, 2, Y. Feller1, 2, N. Eretz Kdosha1, R. Zauner3, J. Pinon Hofbauer3, R. Shalom-Feuerstein4, V. Wally3, U. Koller3, R. Zaidel-Bar2, L. Samuelov1, 2, E. Sprecher1, 2
1Tel Aviv Medical Center, Tel Aviv, Israel, 2Tel Aviv University, Tel Aviv, Israel, 3Paracelsus Medical University, EB House Austria, Salzburg, Austria, 4Technion Israel Institute of Technology, Haifa, Israel

13.35 PM-13.45          ORAL 073    [POSTER 849 ]
Twin prime editing for restoring type VII collagen expression in primary recessive dystrophic epidermolysis patient cells
M. Osborn, B. Steinbeck, A. N. McElroy, J. Tolar
Pediatrics, University of Minnesota Twin Cities, Minneapolis, Minnesota, United States

13.45-13.55           ORAL 074    [POSTER 884 ]
Reproducible correction of COL7A1 nonsense variants with ABE8e adenine base editor
J. K. Jackow1, A. Sheriff1, I. Guri1, I. Brooks1, M. Dimitrievska1, G. Newby2, D. Liu2, L. Laczmanski3, J. A. McGrath1
1St John’s Institute of Dermatology, King’s College London, London, United Kingdom, 2Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States, 3Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland

13.55-14.05           ORAL 075    [POSTER 875 ]
ELX-02 suppress premature stop mutations and restores type VII collagen and laminin 332 function in RDEB and JEB
Y. Hou1, X. Tang1, L. Bainvoll1, S. Aghamohammadzadeh2, M. Chen1
1Dermatology, University of Southern California, Los Angeles, California, United States, 2Eloxx Pharmaceuticals, Watertown, Massachusetts, United States

14.05-14.15           ORAL 076    [POSTER 861 ]
CTSZ pathogenic variants affect EGFR expression and cause autosomal dominant palmoplantar keratoderma
K. Malovitski1, 2, O. Sarig1, Y. Feller1, 2, S. Bergson1, 2, S. Assaf1, 2, J. Mohamad1, 2, M. Pavlovsky1, M. Giladi2, 3, E. Sprecher1, 2
1Division of Dermatology, Tel Aviv Medical Center, Tel Aviv, Israel, 2Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel, 3Department of Internal Medicine D, Tel Aviv Medical Center, Tel Aviv, Israel

14.15-14.25           ORAL 077    [POSTER 807 ]
Alternative mRNA splicing regulates epidermal differentiation
S. Takashima1, 3, W. Sun2, A. Otten1, P. Cai2, J. Bui1, M. Mai1, O. Amarbayar1, B. Cheng1, E. Tong1, Z. Li2, K. Qu2, B. Sun1
1Department of Dermatology, University of California San Diego, La Jolla, California, United States, 2Division of Molecular Medicine, University of Science and Technology of China, Hefei, Anhui, China, 3Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan

14.25-14.35           ORAL 078    [POSTER 812  ]
Regulation of keratinocyte proliferation and differentiation by nucleoporins through nucleocytoplasmic trafficking and direct chromatin binding
X. Bao, A. Neely, Y. Zhang, H. Zhang
Northwestern University, Evanston, Illinois, United States

14.35 PM-14.45           ORAL 079    [POSTER 864  ]
Homologous recombination is prevalent in normal keratinocytes in vivo in mice
G. Egawa, K. Kabashima
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan

14.45-14.55           ORAL 080    [POSTER 840 ]
Excess klhl24 impairs skin wound healing by degradation of vimentin
Y. Liu1, J. Cui2, J. Zhang2, Z. Chen1, Z. Song1, D. Bao1, R. Xiang1, D. Li1, Y. Yang1
1Affiliated Hospital for Skin Diseases of Chinese Academy of Medical Sciences, Nanjing, Jiangsu, China, 2Peking University First Hospital, Beijing, China

14.55-15.05           ORAL 081    [POSTER 860 ]
Fragile WWOX gene maintains genome integrity in fibroblasts
H. Cheng2, Y. Chou3, C. Hsu2, L. Hsu1
1Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University College of Medicine, Tainan, Taiwan, 2Department of Dermatology, National Cheng Kung University College of Medicine, Tainan, Taiwan, 3Institute of Basic Medical Sciences, National Cheng Kung University College of Medicine, Tainan, Taiwan

15.05-15.15           ORAL 082    [POSTER 882 ]
Enhancer RNA (eRNA) profiling to understand transcription regulation in keratinocytes
M. T. Patrick, M. Sarkar, Z. Zhang, H. Zhang, J. T. Elder, J. Gudjonsson, L. C. Tsoi
University of Michigan, Ann Arbor, Michigan, United States

15.15-15.25           ORAL 083    [POSTER 877 ]
Loss of UBE2N in keratinocytes leads to skin inflammation and immune infiltration through IRAK1/4-mediated processes
M. Lee1, 2, M. Ben Hammouda1, W. Miao1, Y. J. Jin1, Y. Huang1, H. Sun1, V. Markovtsov3, J. Y. Zhang1
1Dermatology, Duke University School of Medicine, Durham, North Carolina, United States, 2Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, United States, 3Rigel Pharmaceuticals Inc, South San Francisco, California, United States

15.25-15.35           ORAL 084    [POSTER 808 ]
Seizures in Sturge-Weber syndrome are associated with disrupted calcium metabolism
D. Zecchin1, 2, N. Knoepfel1, 2, 3, A. K. Gluck4, M. Stevenson4, H. Richardson3, S. Polubothu2, 3, A. Inoue5, K. Lines4, A. Chesover3, T. Jacques3, 2, F. Hannan4, U. Loebel3, R. Semple6, R. V. Thakker4V. A. Kinsler1, 2, 3
1The Francis Crick Institute, London, London, United Kingdom, 2University College London, London, London, United Kingdom, 3Great Ormond Street Hospital for Children NHS Foundation Trust, London, London, United Kingdom, 4University of Oxford, Oxford, Oxfordshire, United Kingdom, 5Tohoku Daigaku, Sendai, Miyagi, Japan, 6University of Edinburgh, Edinburgh, United Kingdom

15.35-15.45           ORAL 085    [POSTER 841 ]
A vitiligo-associated SNP (rs706779) controls IL15RA isoforms and T cell activation in epidermal keratinocytes
K. Okamura1, 2, S. Shan3, Q. Tang1, 4, P. Vangala3, X. Fan1, C. Salomão Lopes3, Y. Cao3, W. Ko3, T. Suzuki2, A. Khvorova4, M. Garber3, J. E. Harris1
1Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States, 2Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan, 3Department of Bioinformatics and Computational Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States, 4RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States

Tissue Regeneration and Wound Healing
Room:
Room F (Harmony) – 44F (main tower)
Chairs: Sung-Jan Lin, Xiaomin Bao, Kaisa Tasanen

13.15-13.25           ORAL 086    [POSTER 1512 ]
Combined transcriptome and epigenome profiling reveal regulators of dermal fibroblast state switch
T. Kirk, A. Ahmed, J. Connelly, E. Rognoni
Queen Mary University of London, London, United Kingdom

13.25-13.35           ORAL 087    [POSTER 1448 ]
Ligand-dependent Wnt signaling attenuates mechanotransduction and protects against wound occlusion-mediated abolishment of hair follicle regeneration
A. S. Oak, Y. Zheng, A. Nace, R. Yang, A. Ray, G. Cotsarelis
Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States

13.35-13.45           ORAL 088    [POSTER 1478 ]
TEM1/endosialin/CD248 promotes pathologic scarring by augmenting TGF-β activity through its receptor stability in dermal fibroblasts
Y. Hong1, 2, 4, Y. Lin1, 2, Y. Chang1, Y. Huang1, J. A. McGrath1, 6, H. Wu2, 3, 4, C. Hsu1, 2, 5
1Department of Dermatology, National Cheng Kung University, Tainan, Taiwan, 2International Center for Wound Repair and Regeneration (iWRR), National Cheng Kung University, Tainan, Taiwan, 3Department of Biochemistry and Molecular Biology, National Cheng Kung University, Tainan, Taiwan, 4The Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan, 5Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan, 6St John’s Institute of Dermatology, School of Basic and Medical Biosciences, King’s College London, London, London, United Kingdom

13.45-13.55           ORAL 089    [POSTER 1475 ]
Single cell RNA-seq reveals cell-type specific circadian regulations in the mouse dermis
J. Duan1, M. Ngo1, S. Karri2, J. Lowengrub1, B. Shahbaba1, B. Andersen2
1Center for Complex Biological Systems, University of California Irvine, Irvine, California, United States, 2Department of Biological Chemistry, University of California Irvine, Irvine, California, United States

13.55-14.05           ORAL 090   [POSTER 1480  ]
CXCR4 expression by regulatory T cells promotes cutaneous tissue regeneration
J. Cohen, M. Rosenblum
Dermatology, University of California San Francisco, San Francisco, California, United States

14.05-14.15          ORAL 091   [POSTER 1518 ]
Identification of gene products from staphylococcus aureus that inhibit keratinocyte migration and wound repair
M. D. Bagood1, A. Horswill2, R. L. Gallo1
1Dermatology, University of California San Diego, La Jolla, California, United States, 2Immunology & Microbiology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States

14.15-14.25          ORAL 092   [POSTER 1493 ]
Dynamic changes in fibroblast subpopulations drives development of radiation-induced skin fibrosis through the fra/c-jun pathway
D. C. Wan, M. Griffin, C. E. Berry, M. T. Longaker
Surgery, Stanford University School of Medicine, Stanford, California, United States

14.25-14.35          ORAL 093   [POSTER 1520 ]
Tissue mechanics driven symmetry breaking and cellular reprogramming during regenerative wound healing
H. Harn1, C. Huang1, 2, 3, C. Chen1, 4, A. Sarkar5, B. Van Handel5, T. E. Woolley6, D. Evseenko5, C. Chuong1
1Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States, 2Ostraw School of Dentistry, University of Southern California, Los Angeles, California, United States, 3Division of Cardiovascular Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, 4The IEGG and Animal Biotechnology Center, National Chung Hsing University, Taichung, Taiwan, 5Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, United States, 6Cardiff University School of Mathematics, Cardiff, United Kingdom

14.35-14.45          ORAL 094   [POSTER 1541 ]
Co-transcription factors YAP and TAZ regulate dermal extracellular matrix homeostasis and scar formation in mouse skin
A. Ermilov, Z. Qin, A. Kim, T. Quan, J. J. Voorhees, G. J. Fisher
Dermatology, University of Michigan, Ann Arbor, Michigan, United States

14.45-14.55          ORAL 095   [POSTER 1453 ]
LncRNA SNHG26 facilitates inflammatory to proliferative state transition of keratinocyte progenitors during wound healing
D. Li1, 2, Z. Liu2, L. Zhang2, X. Bian2, J. Wu3, L. Li1, L. Pan1, Y. Xiao1, J. Wang1, X. Zhang1, W. Wang4, M. Toma2, M. Piipponen2, L. Luo2, P. Sommar2, N. Xu Landén2
1Affiliated Hospital for Skin Diseases of Chinese Academy of Medical Sciences, Nanjing, Jiangsu, China, 2Karolinska Institutet, Stockholm, Stockholm, Sweden, 3Wenzhou Medical University, Wenzhou, Zhejiang, China, 4East China Normal University, Shanghai, Shanghai, China

14.55-15.05          ORAL 096   [POSTER 1506 ]
Multimodal transcriptomics highlight fibroblast heterogeneity and pathological signaling networks in keloid
Y. Liu1, 2, C. F. Guerrero-Juarez2, Q. Nie2, J. Li1, M. Plikus2
1Xiangya Hospital Central South University, Changsha, Hunan, China, 2University of California Irvine School of Biological Sciences, Irvine, California, United States

15.05-15.15          ORAL 097   [POSTER 1519 ]
Topical type VII collagen increased elastic fiber formation, accelerated wound closure and reduced scarring of diabetic pigskin wounds.
D. Woodley, Y. Hou, X. Tang, C. Tan, K. Zhang, L. Bainvoll, W. Li, M. Chen
Dermatology, University of Southern California, Los Angeles, California, United States

15.15-15.25          ORAL 098   [POSTER 1500 ]
FoxO3a-regulating mitochondrial dynamics affects wound healing through regulating fibroblast migration
S. Goto1, M. Moriyama2, M. Wakatake3, Y. Miyake1, H. Moriyama1
1Kinki Daigaku, Higashiosaka, Osaka, Japan, 2Kinki Daigaku, Higashiosaka, Osaka, Japan, 3Kinki Daigaku, Higashiosaka, Osaka, Japan

15.25-15.35          ORAL 099   [POSTER 1507  ]
MCSP+ pericytes on the dermal capillary loop as a potential source for epidermal stem/ progenitor cells and their reduction with age.
M. Sawane, T. Tsutsui, M. Komata, R. Kami, H. Aoki, K. Kajiya
MIRAI Technology Institute, Shiseido Co., Ltd, Yokohama, Japan

15.35-15.45          ORAL 100   [POSTER 1455 ]
Identification and characterization of specific subsets in systemic sclerosis fibroblast cultures
A. S. Rosendahl1, K. Schönborn1, N. Kleinenkuhnen2, T. Baar2, A. Tresch2, B. Eckes1, P. Moinzadeh3, T. Krieg1
1Translational Matrix Bioogy, Faculty of Medicine, Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany, 2Institute of Medical Statistics and Computational Biology, Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany, 3Department of Dermatology, Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany

Deciphering pathways in the syndromic keratodermas: insights into oesophageal cancer
David Kelsell

Room: Room A (Concord Ballroom) – 5F  (main tower)
Chair: Sabine Eming

Symposium for Platinium Sponsor

Sanofi Symposium
Title:  Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis: Research breakthroughs leading to therapeutic innovations for patients with atopic dermatitis
Room: Room B (Eminence Hall) – 5F (south tower)

PROGRAM

Chair: Masayuki Amagai

Role of Type 2 Inflammation in Chronic Inflammatory Diseases
Constance Katelaris

Importance of Skin Barrier Dysfunction in Driving AD Pathophysiology
Lisa A. Beck

Connection Between Type 2 Inflammation and the Neuroimmune Mechanisms and Pruritus in AD
Tilo Biedermann

ePoster Stage 1: Adaptive and Auto-Immunity I & II
Chairs: Hayato Takahashi, Sam Hwang, Manuela Pigors 

ePoster Stage 2: Carcinogenesis and Cancer Genetics/Photobiology & Skin of Color
Chairs: Jong Hee Lee, Snehlata Kumari, Nabiha Yusuf and Beate Lichtenberger

ePoster Stage 3: Clinical Research – Epidemiology and Observational Research I & II 
Chairs: Young Lee, Helmut Schaider, Howa Yeung, and Marie-Charlotte Brüggen

ePoster Stage 4: Genetic Disease, Gene Regulation, and Gene Therapy
Chairs: Rei Watanabe, Rui Yi, Fernando Larcher

ePoster Stage 5: Tissue Regeneration and Wound Healing/Skin, Appendages, and Stem Cell Biology 
Chairs: Doyoung Kim, Bethany Perez White, Hisham Bazzi

ePoster discussions will take place in the Poster Hall space (NS Building) on our five ePoster stages.

ePoster Stage 1: Adaptive and Auto-Immunity I & II
Chairs: Hayato Takahashi, Sam Hwang, Manuela Pigors 

037 The intra-niche activation of clonal CXCL13+CD4+ T cells in tertiary lymphoid structures associated with non-healing blisters of pemphigus
A. Lee

064 CD301b+ dermal dendritic cells drive activation of cytotoxic T lymphocytes in a murine contact dermatitis
F. Minami

003 Memory B cells of atopic individuals preferentially express IL-31RA: a putative role of IL-31 in B cell biology
Z. Unger

070 Impact of autoantibodies on atopic dermatitis
T. Hisamoto

121 Pharmacological inhibition of the neonatal Fc receptor reduces disease activity in an antibody transfer-induced model of bullous pemphigoid
M. Pigors

168 TLR7-VGLL3 synergism potentiates lupus-like autoimmunity in mice
O. Plazyo

056 IKZF1 and IKAROS overexpression contributes to the pathogenesis of alopecia areata
Y. Arakawa

039 Inhibitory effect on skin fibrosis by regulating Th17 and regulatory T cell imbalance in a systemic sclerosis mouse model and the involvement of alteration in the intestinal microbiota
A. Sekiguchi

014 Sex as a variable in the composition of skin residing T cells
H. Koguchi-Yoshioka

073 Arteriosclerosis derived from cutaneous inflammation is ameliorated by the deletion of IL-17A or IL-17F
T. Nakanishi

166 Granzyme K stimulates a novel pathway of complement activation
E. Theisen

079 Generation and characterization of the Psmb8 G201V mutation knock-in mice as a model for Nakajo-Nishimura syndrome
T. Hara

016 Immune competent skin organoids reveal monkeypox dynamics
A. J. Pavlovitch-Bedzyk

053 Conformational epitope mapping of autoantibodies against BP180 in dipeptidyl peptidase-4 inhibitors-associated bullous pemphigoid
S. Mai

075 Cellular subsets and signaling pathways of IgA vasculitis revealed by single-cell RNA sequencing
D. Tie

160 Local precursors are capable of replenishing tissue-resident memory T cells in healthy and diseased skin
E. Hoffer

002 Gene flow from archaic hominins causes psoriasis, ankylosing spondylitis, and Behçet’s disease
A. Arakawa

ePoster discussions will take place in the Poster Hall space (NS Building) on our five ePoster stages.

ePoster Stage 2: Clinical Research – Epidemiology and Observational Research I & II 
Chairs: Young Lee, Helmut Schaider, Howa Yeung, and Marie-Charlotte Brüggen

563 Increased incidence of cutaneous melanoma and merkel cell carcinoma in subgroups of patients with primary cutaneous B-cell lymphoma: A SEER database analysis
L. Banner

411 Associations between immune-related diseases and skin cancer: An analysis of the diverse All of US research program
E. M. Lin

475 Skin of color and mucocutaneous ulcers are associated with increased disease severity in anti-NXP2 dermatomyositis patients
C. Bax

485 Sleep disturbance impacts physical and psychosocial health of children with atopic dermatitis
C. Mann

461 Total serum IgE levels as a predictor for clinical response to omalizumab in patients with chronic spontaneous urticaria: A systematic review and meta-analysis
H. C. Chang

408 Disaggregated analysis of Asian ethnicities reveals disparities in melanoma treatment timeliness
L. S. Fane

561 Can systemic levels of BNP predict itch severity?
L. A. Nattkemper

442 The influence of psoriasis on clinical outcomes following burn Injury
D. Thomas

419 Comparison of topical fluorouracil and cryotherapy in Medicare patients with actinic keratoses: A retrospective cohort study
M. K. Nowakowska

565 Assessing postoperative complication risk in patients with pre-existing diabetes mellitus who undergo mohs micrographic surgery
D. Garate

473 Clinical characteristics and risk of second malignancies of extramammary paget’s disease patients in Canada and Japan
F. Al Ghazawi

463 Comorbid conditions associated with alopecia areata: A systematic review and update
S. Ly.

513 Zinc dyshomeostasis in patients with bullous pemphigoid and BP180-deficient mice
C. Chu

426 Association of stratum corneum and breast milk factors with the development of atopic dermatitis in infancy: A prospective birth cohort study
R. Fukuda

468 Use of calcitonin gene-related peptide monoclonal antibodies in patients with rosacea: An exploratory, comparative case series
T. Sia

392 Hair loss after drug reaction with eosinophilia and systemic symptoms: A multicentric retrospective study
J. Lee

452 Validation of LRINEC score and establishment of novel score in Japanese patients with necrotizing fasciitis
Y. Norimatsu

ePoster discussions  will take place in the Poster Hall space (NS Building) on our five ePoster stages.

ePoster Stage 3: Tissue Regeneration and Wound Healing/Skin, Appendages, and Stem Cell Biology 
Chairs: Doyoung Kim, Bethany Perez White, Hisham Bazzi

1458 Dissection of the molecular and cellular heterogeneity of dermal fibroblasts in skin fibrosis
A. Ahmed

1446 RNase L acts as a regeneration suppressor
C. Kirby

1516 Genetic mouse models and a new pro-lymphangiogenic treatment approach reveal beneficial effects of lymphatic vessel activation in cutaneous wound healing
M. Detmar

1473 Hippo pathway drives excessive fibrosis in hidradenitis suppurativa
K. R. van Straalen

1479 The cutaneous ischemia-reperfusion injury-induced pressure ulcer was attenuated in amyotrophic lateral sclerosis mice model via decreased nerve neurons and neuro peptides resulting in suppressing oxidative stress.
A. Uchiyama

1539 A paradigm shift: Inflammatory response in chronic wounds halts progression of healing
M. Tomic-Canic

1468 Lymphatic dysfunction affects both collagen degradation and collagen synthesis, leading to a paradoxical reduction in dermal fibrosis
M. Sugaya

1511 Macrophages regulate endothelial progenitors’ quiescence and self-renewal during homeostasis and cutaneous wound healing via paracrine signaling
S. Sim

1482 Physical stress reveals stem cell resources in nail
H. Kosumi

1440 DNA dioxygenases Tet2/3 regulate gene promoter accessibility and chromatin topology in lineage-specific loci to control keratinocyte differentiation and hair growth
G. Chen

1349 Inducing fate changes at the hair follicle stem cell nice
C. Clavel

1391 Cell death functions in hair follicle regeneration
G. Mantellato

1428 DKK2 and SOSTDC1 cooperate to initiate the first catagen phase of the hair follicle growth cycle
A. Ho

1372 Modulation of YBX1 phosphorylation determines epidermal stem cell function.
S. Iriyama

1378 A multi-omics approach to identifying factors involved in hair follicle growth and development
N. Pantelireis

1346 Functional roles of Krox20 (Egr2) in Epithelial Stem Cells
E. Ghotbi

1413 From force to fate: LINCing cell junctions to nuclear morphology
A. Banerjee

ePoster discussions will take place in the Poster Hall space (NS Building) on our five ePoster stages.

ePoster Stage 4: Carcinogenesis and Cancer Genetics/Photobiology & Skin of Color 
Chairs: Jong Hee Lee, Snehlata Kumari, Nabiha Yusuf and Beate Lichtenberger

291 Dysregulation of N6-methyladenine DNA methylation as a new epigenetic mechanism in skin tumorigenesis
Y. He

271 The invasive niche confers resistance to therapy in basal cell carcinoma
F. Kuonen

308 Immuno cancer-associated fibroblasts are a major source of cytokines in malignant skin cancer
B. Aschenbrenner

256 Non-canonical control of hedgehog signaling in skin basal cell carcinoma
R. Iglesias-Bartolome

232 Epidermal mutation accumulation in photodamaged skin is associated with skin cancer burden and can be targeted through ablative therapy
H. Wong

236 Visualizing somatic alterations in spatial transcriptomics data of skin cancer
H. Shain

235 Distinct biological pathways associated with individual stages of tumor progression in KIT-altered melanoma
E. Everdell

293 Acidosis promotes immune escape through the IFN-γ-induced induction of PD-L1 transcription in cancer cells
D. Stowbur

274 Homologous recombination deficiency scores in AK and cSCC are associated with tumor-immune phenotype
J. Thomson

1178 Mechanisms of type I interferon-mediated UVB sensitivity in human keratinocytes
N. Haddadi

1170 Investigating the molecular mechanisms of solar urticaria
M. Peake

1175 Impact of low dose UVA radiation on UVB radiation-induced DNA damage and skin carcinogenesis
K. M. Rolfes,

1142 The IL-1α stimulated expression of the wrinkle-inducing elastase neprilysin in adult human dermal fibroblasts is mediated via an intracellular signaling axis of ERK/JNK/c-Jun/c-Fos/AP-1
U. C. Pinnawala

1165 PDT-resistant skin tumor cells secrete CCL2 to induce TAMs recruitment and suppressive tumor microenvironment.
Y. Fu

1310 Characterization of differences in epidermal lipid composition between psoriatic skin of color and white psoriatic skin
R. Haughton

1317 S6K2 is a vulnerability in MAPK-driven acral melanoma
R. Brathwaite

1292 Molecular phenotyping of keloid skin samples suggests polar immune dysregulation
J. Bar

1314 The JAK/STAT signaling pathway: Considerations in the management of hidradenitis suppurativa in skin of color
C. A. Okeke

ePoster discussions will take place in the Poster Hall space (NS Building) on our five ePoster stages.

ePoster Stage 5: Genetic Disease, Gene Regulation, and Gene Therapy
Chairs: Rei Watanabe, Rui Yi, Fernando Larcher

818 Multi-condition TWAS for inflammatory skin disorders highlights roles of genetic signals in cytokine-stimulated keratinocytes
H. Zhang

862 Hedgehog signaling and ENPP1 role in epidermal proliferation and melanin synthesis
M. Pavlovsky

903 Utilizing an organoid-based approach for the derivation of genetically corrected keratinocytes and fibroblasts in an induced pluripotent stem cell therapy for skin diseases
M. Pavlova

878 CRISPR/Cas9 targeting an intronic region retrieving protein expression in a compound heterozygous model mice via inducing revertant mosaicism pathways
H. Nguyen

803 Editing a missense to a nonsense keratin 9 gene mutation restores intermediate filament integrity
T. Trafoier

899 Phenotypic and genomic characterization of eight patients with patterned cutaneous hypopigmentation associated with extracutaneous findings
Z. Cai

825 Basement membrane proteins in NF1-associated neurofibroma extracellular matrix characterize tumor development and treatment response to MEK inhibitor
L. Q. Le

To encourage delegates to communicate with each other actively and provide the opportunity for networking while indulging in Japanese culture, Japanese traditional festival style called “En-nichi” will be arranged. Delegates can enjoy rows of stalls of local Japanese food. At the end of the gathering, delegates will be cordially invited to join the circle of “Bon-Odori” (bon dancing).

Date: Thursday 11 May 2023
Venue: Keio Plaza Hotel
Rooms:
Room A (Concord Ballroom) and Room B (Eminence Hall)

Entrance fees: $35
BOOK YOUR SEAT HERE

From 10 May – Onsite, please visit the ISID 2023 Meeting Registration
Counter in the Room HANA C/D for ticket availability.

Friday 12 May 2023

Day Three

JSID General Assembly – Room B
SID General Assembly – Room C
ESDR General Assembly – Room D
TSID General Assembly – Room E

2023 David Martin Carter Mentor Award
2023 George W. Hambrick Award
2023 Research Achievement Award in Autoimmune and Inflammatory Skin Disorders
2023 Research Achievement Award in Skin Cancer and Melanoma
2023 Research Achievement Award in Psoriasis
2023 Research Achievement Award in Vitiligo and Pigment Cell Disorders
2023 Research Achievement Award in Public Policy and Medical Education
2023 Research Achievement Award in Discovery
2023 Research Achievement Award in Translational Research

Satellite Symposium 
Title: Photobiology Symposium

Virtual:
Free registration HERE
Download the program HERE

Room: Room A (Concord Ballroom) – 5F  (main tower)
Chairs: Hsin-Su Yu, Jeffrey Travers, Enikö Sonkoly

08.10-08.22           ORAL 101   [POSTER 025  ]
Interstitial lung disease based on autoimmunity against melanoma differentiation-associated gene 5
Y. Ichimura1, 3, R. Konishi1, 3, T. Nomura3, M. Fujimoto2, N. Okiyama1
1Department of Dermatology, Tokyo Ika Shika Daigaku Daigakin Ishigaku Sogo Kenkyuka, Bunkyo-ku, Tokyo, Japan, 2Department of Dermatology, Osaka Daigaku, Suita, Osaka, Japan, 3Department of Dermatology, Tsukuba Daigaku Igaku Iryokei, Tsukuba, Ibaraki, Japan

08.22-08.34           ORAL 102   [POSTER 1164 ]
Naive HIF-1a/ AhR keratinocyte-conditional double knockout mice resemble UVB-irradiated wildtype mice
S. Fassbender1, 2, J. Schindler1, 2, H. Ramachandran1, T. Nguyen1, M. Majora1, T. Haarmann-Stemmann1, C. Esser1, A. Rossi1, H. Weighardt2, 1, J. Krutmann1
1IUF – Leibniz-Institut fur umweltmedizinische Forschung GmbH, Dusseldorf, Nordrhein-Westfalen, Germany, 2LIMES Life and Medical Sciences Institute, Rheinische Friedrich-Wilhelms-Universitat Bonn, Bonn, Nordrhein-Westfalen, Germany

08.34-08.46           ORAL 103   [POSTER 539 ]
Multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: A population-level analysis
W. Chen1, 2, G. Wan1, 2K. Roster1, N. Nguyen1, A. Rajeh1, H. Rashdan1, M. Collier1, J. Seo1, N. LeBoeuf4, 2, S. Kwatra3, Y. Semenov1, 2
1Massachusetts General Hospital, Boston, Massachusetts, United States, 2Harvard Medical School, Boston, Massachusetts, United States, 3Johns Hopkins University, Baltimore, Maryland, United States, 4Dana-Farber Cancer Institute, Boston, Massachusetts, United States

08.46-08.58            ORAL 104   [POSTER 225  ]
Enhanced TLR7 immunity drives innate protection against SARS-CoV-2 with chilblains as collateral damage.
A. Yatim1, 2, 3, F. Saidoune1, J. Di Domizio1, R. Jenelten1, A. Joncic1, M. Morren1, C. Conrad1, J. Casanova2, 3, M. Gilliet1
1Department of Dermatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Vaud, Switzerland, 2Institut Imagine Institut des Maladies Genetiques, Paris, Île-de-France, France, 3The Rockefeller University, New York, New York, United States

08.58-09.10            ORAL 105   [POSTER 732  ]
Dysregulated cytosolic Ca2+ concentration in channel-related keratoses
T. Murata1, 2, N. Kanazawa1, K. Kabashima2
1Department of Dermatology, Hyogo Medical University, Nishinomiya, Japan, 2Department of Dermatology, Kyoto University, Kyoto, Japan

RNA origin of sex-biased immunity
Howard Chang

Room: Room A (Concord Ballroom) – 5F  (main tower)
Chair: Ken Tsai

Adiponectin and Skin Diseases
Jin-Ho Chung

Room: Room A (Concord Ballroom) – 5F  (main tower)
Chair: Eung Ho Choi 

Room: Room A (Concord Ballroom) – 5F  (main tower)
Chairs: Johannes Kern, Cory Simpson, Christoph Schlapbach

10.20-10.32            ORAL 106   [POSTER 916 ]
Activation of the pentose phosphate pathway in macrophages is essential for granuloma formation in sarcoidosis
S. Nakamizo1, G. Egawa1, Y. Ishida1, Y. Sugiura1, K. Kabashima1, 2
1Kyoto Daigaku, Kyoto, Japan, 2Agency for Science, Technology and Research, Singapore, Singapore

10.32-10.44            ORAL 107   [POSTER 1124 ]
Strong preclinical evidence for treatment efficacy of a novel immune checkpoint inhibitor (ICI) in melanoma that targets a rare heparan sulfate
J. Chung1, 2, S. Ung1, 2, J. Gill1, P. Cruz1, 2, K. Ariizumi1, 2
1Dermatology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States, 2North Texas VA Medical Center, Dallas, Texas, United States

10.44-10.56            ORAL 108   [POSTER 1431 ]
Skin aging and hair follicle stem cell dysfunction caused by T cells with defective mitochondrial metabolism
E. Carrasco1, 2, 3, E. Gabandé-Rodríguez2, 4, G. Soto-Heredero2, 4, M. M. Gómez de las Heras2, 4, M. Mittelbrunn2
1Department of Biology, Faculty of Sciences, Universidad Autonoma de Madrid, Madrid, Spain, 2Tissue and Organ Homeostasis Program, Universidad Autonoma de Madrid Centro de Biologia Molecular Severo Ochoa, Madrid, Spain, 3Experimental Dermatology, Instituto Ramon y Cajal de Investigacion Sanitaria, Madrid, Spain, 4Department of Molecular Biology, Faculty of Sciences, Universidad Autonoma de Madrid, Madrid, Spain

10.56-11.08            ORAL 109   [POSTER 017  ]
A novel therapeutic strategy using stabilized antigen-specific iTreg for pemphigus
M. Mukai1, H. Takahashi1, N. Mikami2, S. Sakaguchi2, M. Amagai1
1Dermatology, Keio University School of Medicine, Tokyo, Japan, 2Experimental Immunology, Osaka University IFReC, Osaka, Japan

11.08-11.20            ORAL 110   [POSTER 1567 ]
Single-cell rna sequencing reveals unique fibroblast subclusters in prurigo nodularis
J. R. Patel1, M. Joel1, K. Lee1, A. Kambala1, H. Cornman1, O. O. Oladipo1, M. Taylor1, J. Deng1, V. Parthasarathy1, M. Marani1, S. Reddy1, T. Pritchard1, V. Rebecca1, W. Ho1, M. Kwatra2, X. Dong1, S. Kang1, S. Kwatra1
1Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States, 2Duke University School of Medicine, Durham, North Carolina, United States

Precision Medicine of Common Diseases
Pui-Yan Kwok

Room: Room A (Concord Ballroom) – 5F  (main tower)
Chair: Fu-Tong Liu

Symposium for Gold Sponsor

Janssen Symposium
Title: Unlocking the IL-23 pathway: looking back to move forward for psoriasis management
Room: Room A (Concord Ballroom) – 5F  (main tower)
Boxed lunch provided

PROGRAM

12:05 Welcome and introduction: Akimichi Morita
Objective: Welcome attendees and introduce programme

12:10 Past perspectives are key: IL-23 as the key cytokine in psoriatic disease
Dan Cua
Objective: Discuss the journey of IL-23, from its discovery to the impact it has had on the clinic.

12:20 The guiding light: disease memory and early intervention in psoriasis
Andreas Pinter
Objective: Provide the latest insights on how early intervention by targeting the Th17/IL-23 pathway could maintain long-term disease control.

12:30 Diverging threads: small changes, big implications?
James G. Krueger
Objective: Provide new insights into the mechanisms of action of IL-23 inhibitors and discuss how these mechanisms can potentially affect their therapeutic profiles of these drugs.

12:40 Looking forward: panel discussion and Q&A
All faculty; moderated by Prof. Morita

13:00 Closing remarks
Prof. Morita

Symposium for Gold Sponsor

Nippon Boehringer Ingelheim Symposium
Title: Latest research on pustular skin diseases
Room: Room B (Eminence Hall) – 5F (south tower)
Boxed lunch provided

PROGRAM:
Chair: Masashi Akiyama

The Role of IL-36 in Pustular Psoriasis: What Have We Learnt from Genetic Studies?
Francesca Capon

The Role of Neutrophils in Skin Diseases
Tatsuyoshi Kawamura

Symposium for Gold Sponsor

No 7 Beauty Company Symposium
Title: Matrix-derived Cosmetic Peptides (matrikines) for the Rejuvenation of Photoaged Skin
Room: Room C (Nishiki) – 4F (south tower)
Boxed lunch provided

PROGRAM:

12.05 – 12.10 Welcome
Mike Bell

12.10-12.25 Predicting matrix-derived peptides using in silico machine learning approaches
Objective: How protein susceptibility algorithms and machine learning approaches can be used to predict breakdown of extracellular matrix proteins and the release of putative bioactive peptides called ’matrikines’.
Mike Sherratt

12.25 – 12.40 Novel peptides identified using machine learning approaches show wide-ranging activity in cultured human dermal fibroblasts
Objective: Evidence that novel ‘matrikine’ peptides identified using machine learning approaches show dermal remodelling activity in vitro; utilising a range of techniques including omics.
Alexander Eckersley

12.40-12.55 A novel peptide-blend has potential as a topical anti-ageing cosmeceutical; Evidence from a short-term patch test protocol for skin remodelling
Objective: Evidence that a novel peptide-blend first identified using machine learning shows promise as a topical anti-ageing cosmeceutical, based on a validated short-term patch test protocol to assess skin remodelling in photoaged skin using immunohistochemical markers and transcriptomic characterisation.
Rachel Watson

Symposium for Gold Sponsor

Shiseido Symposium
Title: Skin Beauty Provided by Healthy Blood and Lymphatic Vascular Systems
Room: Room D (Ohgi) 4F (south tower)
Boxed lunch provided

PROGRAM:
Chair: Kenji Kabashima

The Importance of Blood Vessels and Lymphatic Vessels for Skin Health, Aging and Beauty
Michael Detmar

Holistic Beauty by Promoting Blood/Lymphatic Vessel Function in Skin
Kentaro Kajiya

Symposium for Gold Sponsor

LEO Pharma Symposium
Title: Updated Information About the Roles of IL-13 in Atopic Dermatitis
Room: Room E (Moonlight) – 43F (main tower)
Boxed lunch provided

PROGRAM:
Chairs: Takeshi Nakahara, and Chih-ho Hong

The Roles of IL-13 in Atopic Dermatitis 
Kenji Izuhara

Symposium for Gold Sponsor

Torii Pharmaceutical Company, LTD. Symposium
Title: Understanding the Pathogenesis of Atopic Dermatitis
Room: Room F (Harmony) – 44F (main tower)
Boxed lunch provided

PROGRAM:
Chair: Norito Katoh

Itch of Atopic Dermatitis and Janus Kinase: Chasing the Itch Jackpot
Takashi Hashimoto

Impact of Staphylococcal Agr in Atopic Dermatitis and Systemic Infection
Yumi Matsuoka-Nakamura

Skin T cells in lockdown – regulation of human T cell tissue residency
Christina Zielinski

Room: Room A (Concord Ballroom) – 5F  (main tower)
Chair: Curdin Conrad

Symposium for Platinum Sponsor

Eli Lilly Symposium
Title: Explore Our Future from Investigative Research in Alopecia Areata, Atopic Dermatitis and Psoriasis
Room: Room A (Concord Ballroom) – 5F  (main tower)

PROGRAM:

Chairs: Manabu Ohyama and Chris Griffiths

Eli Lilly’s R&D strategy in Dermatology
Lotus Mallbris

Latest Insights on the Pathogenesis and Treatment of Alopecia Areata
Ohsang Kwon

Unraveling the Heterogeneity of Atopic Dermatitis: “A Closer Look at Longitudinal Course”
Raj Chovatiya

RWE for Clinical Decision Making in Psoriasis
Andreas Pinter

Adaptive and Auto-Immunity 2
Room: Room B (Eminence Hall) – 5F (south tower)
Chairs: Chih-Hung Lee, John Harris and Michael Hertl

15.30-15.40            ORAL 111   [POSTER 157 ]
The tumor microenvironment limits the development and persistence of tissue-resident memory T cells
J. B. Williams, T. S. Kupper
Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts, United States

15.40-15.50            ORAL 112   [POSTER 007 ]
Commensal papillomaviruses role in sun-damaged skin homeostasis
H. G. Son1, D. T. Ha1, R. Guennoun1, J. Strickley1, T. H. Erlich1, D. E. Fisher1, J. Joh2, S. Demehri1
1CBRC, Massachusetts General Hospital, Boston, Massachusetts, United States, 2University of Louisville, Louisville, Kentucky, United States

15.50-16.00            ORAL 113   [POSTER 143 ]
Genetic and transcriptional signatures of merkel cell carcinoma-specific B cells suggest a functional role in modulating cancer immunity
A. J. Remington1, 2, H. J. Rodriguez1, 2, T. Pulliam1, M. D. Gray2, J. J. Taylor2, P. Nghiem1
1Division of Dermatology, University of Washington, Seattle, Washington, United States, 2Vaccine and Infectious Disease Divison, Fred Hutchinson Cancer Center, Seattle, Washington, United States

16.00-16.10            ORAL 114   [POSTER 084 ]
Neoantigen-specific T cell responses constrain cutaneous squamous cell carcinoma
A. C. Adams1, A. M. Macy1, E. S. Borden1, L. M. Herrmann1, K. H. Buetow2, M. A. Wilson2, D. J. Roe3, K. T. Hastings1
1College of Medicine – Phoenix, University of Arizona, Phoenix, Arizona, United States, 2School of Life Sciences, Arizona State University, Tempe, Arizona, United States, 3Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, United States

16.10-16.20            ORAL 115   [POSTER 150 ]
Single-cell RNA sequencing defines disease-specific differences between prurigo nodularis and atopic dermatitis
N. Alkon1, F. P. Assen1, T. Arnoldner1, W. M. Bauer1, M. Medjimorec1, L. Shaw1, K. Rindler1, G. Holzer2, P. Weber1, W. Weninger1, T. Kinaciyan1, M. Farlik1, C. Jonak1, J. Griss1, C. Bangert1, P. Brunner3
1Medizinische Universitat Wien, Wien, Austria, 2Klinik Donaustadt, Vienna, Austria, 3Icahn School of Medicine at Mount Sinai, New York, New York, United States

16.20-16.30            ORAL 116   [POSTER 042 ]
T cell-derived lymphotoxin β receptor signaling forms HEV-like vessels in the skin of atopic dermatitis-like inflammation in mice
S. Kanameishi1, S. Ono1, Y. K. Honda1, 3, R. Asahina1, T. Honda2, K. Kabashima1
1Dermatology, Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu, Kyoto, Kyoto, Japan, 2Dermatology, Hamamatsu Ika Daigaku, Hamamatsu, Shizuoka, Japan, 3Immunology Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia

16.30-16.40            ORAL 117   [POSTER 055 ]
IL-15 contributes to atopic dermatitis pathogenesis: Lessons from a novel humanized mouse disease model
I. Piccini1, O. Egriboz1, K. I. Pappelbaum1, M. Fehrholz1, A. Keren2, R. Paus1, 3, 5, A. Gilhar2, A. Vicari4, M. Bertolini1
1Monasterium Laboratory GmbH, Münster, Germany, 2Technion Israel Institute of Technology, Haifa, Israel, 3Dermatology, University of Miami, Miami, Florida, United States, 4Calypso Biotech BV, Amsterdam, Netherlands, 5CUTANEON, Hamburg, Germany

16.40-16.50            ORAL 118   [POSTER 167 ]
IL-36 axis is female-biased in pustular psoriasis in type I IFN-dependent manner
M. Sarkar1, F. Ma2, 1, A. Kidder1, A. Coon1, B. E. Perez White3, R. Uppala1, N. L. Ward4, C. Dobry1, L. Tsoi1, J. M. Kahlenberg2, J. Gudjonsson1
1Dermatology, University of Michigan, Ann Arbor, Michigan, United States, 2Rheumatology, Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States, 3Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States, 4Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, United States

16.50-17.00            ORAL 119   [POSTER 057 ]
Single-cell RNA sequencing reveals cellular drivers of UV-mediated skin injury in cutaneous lupus
M. P. Maz, F. Ma, M. Gharaee-Kermani, A. Victory, A. Hurst, J. Gudjonsson, J. M. Kahlenberg
University of Michigan, Ann Arbor, Michigan, United States

17.00-17.:10            ORAL 120   [POSTER 094 ]
Periostin – an inducer of pro-fibrotic phenotype in monocytes and monocyte-derived macrophages in systemic sclerosis
M. Suzuki, Y. Ototake, A. Akita, M. Asami, N. Ikeda, Y. Yamaguchi
Yokohama Shiritsu Daigaku Igakubu Daigakuin Igaku Kenkyuka, Yokohama, Kanagawa, Japan

17.10-17.20            ORAL 121   [POSTER 128 ]
A stable, but reversible replicative arrest in alopecia areata
K. Meier1, 2, J. Brück2, T. Mehra3, M. Gassenmaier2, E. Müller-Hermelink1, 2, A. Hossini4, C. C. Zouboulis4, K. Ghoreschi1, 2, M. Röcken2
1Department of Dermatology, Venereology and Allergology, Charite Universitatsmedizin Berlin, Berlin, Germany, 2Department of Dermatology, Eberhard-Karls-Universitat Tubingen Medizinische Fakultat, Tubingen, Baden-Württemberg, Germany, 3Kantonsspital Baselland, Liestal, Basel-Landschaft, Switzerland, 4Department of Dermatology, Venereology, Allergology and Immunology, Stadtisches Klinikum Dessau, Dessau, Sachsen-Anhalt, Germany

17.20-17.30            ORAL 122   [POSTER 169 ]
Vitiligo lesions are driven by the collaboration of expanded CD8+ T cell clones
E. Katz1, A. Manukyan1, K. Gellatly1, M. Wadsworth2, A. Winkler2, W. Ruff3, M. Garber1, J. E. Harris1
1University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States, 2Pfizer Inc, New York, New York, United States, 3Repertoire, Cambridge, Massachusetts, United States

17.30-17.40            ORAL 123   [POSTER 181 ]
The role of nuclear IL-37 in regulating FOXP3 expression and Treg cell stability
D. Osborne1, J. Domenico1, P. K. Vaddi1, Z. Zhai1, C. Dinarello2, 3M. Fujita1, 3, 4
1Dermatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States, 2Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States, 3Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States, 4Veterans Affairs Medical Center, VA Eastern Colorado Health Care System, Aurora, Colorado, United States

17.40-17.50            ORAL 124   [POSTER 095 ]
HLA class II-restricted CD8+ T cells contribute to the promiscuous immune response in dapsone hypersensitive patients
Q. Zhao1, L. Sun1, H. Liu1, D. Naisbitt2, F. Zhang1
1Shandong Provincial Hospital for Skin Diseases, Jinan, Shandong, China, 2University of Liverpool, Liverpool, United Kingdom

17.50-18.00            ORAL 125   [POSTER 097 ]
VDAC as a novel actionable therapeutic target in pemphigus vulgaris
S. Assaf1, 2, O. Sarig1, C. Bilu1, Y. Zoabi2, K. Malovitski1, 2, Y. Feller1, 2, S. Bergson1, 2, V. Shoshan-Barmatz3, N. Shomron2, D. Vodo1, E. Sprecher1, 2
1Tel Aviv Medical Center, Tel Aviv, Israel, 2Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel, 3Ben-Gurion University of the Negev, Beer-Sheva, Israel

Clinical Research: Epidemiology 2
Room: Room C  (Nishiki) – 4F (south tower)
Chairs: Dedee Murrell, Adela Rambi Cardones, Jean Krutmann

15.30-15.40            ORAL 126   [POSTER 402 ]
Antihypertensive medication associated with eczematous dermatitis in older adults
M. Ye1, I. Douglas2, S. Evans2, S. M. Langan2, K. Abuabara1
1Department of Dermatology, University of California San Francisco, San Francisco, California, United States, 2London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, London, United Kingdom

15.40-15.50            ORAL 127   [POSTER 488 ]
Dual blockade of IL-4 and IL-13 with dupilumab reduces severity of type 2 inflammatory immune-related adverse events
C. Lee1, W. Chung2, C. Chen2
1Department of Medical Education, Chang Gung Memorial Hospital, Keelung, Taiwan, 2Drug Hypersensitivity Clinical and Research Center, Department of Dermatology, Chang Gung Memorial Hospital, Linkou, Taipei and Keelung, Taiwan

15.50-16.00            ORAL 128   [POSTER 550 ]
Atopic dermatitis in adolescents: Role of carbonyl reductase 3 genetic risk score under constant chronic exposure to particulate matter
S. Kress1, M. Lau2, C. Wigmann1, F. Hartung1, T. Haarmann-Stemmann1, T. Schikowski1
1IUF Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany, 2Heinrich-Heine-Universitat Dusseldorf, Dusseldorf, Nordrhein-Westfalen, Germany

16.00-16.10            ORAL 129   [POSTER 462 ]
Blood molecular phenotypes of Chinese AD patients
Y. Wang1, Y. Wu1, C. Gu1, X. Yao2, W. Li1
1Department of Dermatology, Huashan Hospital Fudan University, Shanghai, China, 2Department of Allergy and Rheumatology, Affiliated Hospital for Skin Diseases of Chinese Academy of Medical Sciences, Nanjing, Jiangsu, China

16.10-16.20            ORAL 130   [POSTER 382 ]
A novel assessment of cardiovascular health in people with psoriasis in the US: a cross-sectional study
S. Wang1, D. B. Shin1, T. Bhutani2, J. Gelfand1
1Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, United States, 2Dermatology, University of California San Francisco, San Francisco, California, United States

16.20-16.30            ORAL 131   [POSTER 484 ]
The relative abundance of unsaturated fatty acid and their dietary habits in incident psoriatic diseases
Y. Xiao2, D. Jing2, S. Yang2, X. Chen2, M. Shen1
1Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, Changsha, Hunan, China, 2Dermatology, Central South University, Changsha, Hunan, China

16.30-16.40            ORAL 132   [POSTER 509 ]
IL-17A and IL-17F in the pathogenesis of hidradenitis suppurativa: Insights from early and chronic lesions
A. Skelton1, H. Gopee2, R. Okoye1, A. Ferecsko1, M. Page1, S. Shaw1
1UCB Pharma, Slough, United Kingdom, 2Newcastle University, Newcastle upon Tyne, United Kingdom

16.40-16.50            ORAL 133   [POSTER 447 ]
Immunotherapy efficacy in Merkel cell carcinoma is affected by the presence and type of immunosuppression: Analysis of 183 patients
E. Gong1, D. S. Hippe1, X. Fan1, L. Zawacki1, 2, A. J. Remington1, A. Menon1, K. Lachance1, T. Akaike1, S. Park1, P. Nghiem1
1University of Washington, Seattle, Washington, United States, 2Washington State University, Pullman, Washington, United States

16.50-17.00            ORAL 134   [POSTER 430 ]
Merkel cell carcinoma and multiple primary cancers: A SEER-based analysis
E. Eid1, N. Maloney2, Z. Ran Cai1, L. Zaba2, N. Kibbi2, E. M. John3, E. Linos2
1Program for Clinical Research and Technology, Stanford University, Stanford, California, United States, 2Department of Dermatology, Stanford University, Stanford, California, United States, 3Department of Epidemiology & Population Health, Stanford University, Stanford, California, United States

17.00-17.10            ORAL 135   [POSTER 520 ]
A retrospective cohort study of patch testing in oral lichen planus and subsequent diagnosis of oral squamous cell carcinoma.
V. N. Sahni, Z. Hopkins, J. Rhoads, J. Clarke, C. Hansen, D. Powell, R. deShazo, J. Zone, C. Hull
Dermatology, University of Utah Health, Salt Lake City, Utah, United States

17.10-17.20            ORAL 136   [POSTER 508 ]
Prognostic relevance of blood T-cell clonality in mycosis fungoides
D. Joffe, L. Banner, L. Gleason, N. Nikbakht
Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States

17.20-17.30            ORAL 137   [POSTER 410 ]
Clinicopathological factors and outcomes of cutaneous angiosarcoma
S. Yonekura, Y. Endo, K. Kabashima
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan

17.30-17.40            ORAL 138   [POSTER 571 ]
Associations among polymorphisms in FCγRIIIA and treatment responses to rituximab in patients with pemphigus
P. Huang, Y. Cho, C. Chu
Department of Dermatology, National Taiwan University, Taipei, Taiwan

17.40-17.50            ORAL 139   [POSTER 522 ]
Serum levels of alarmins as potential biomarkers to diagnose and predict activity/severity of non-segmental vitiligo
K. He1, W. Wu1, X. Wang1, W. Dai2, S. Wang2, C. Li1, S. Li1
1Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an, China, Xi’an, Shaanxi, China, 2Department of Dermatology and Venereology, Nanfang Hospital, Southern Medical University, Guangzhou, China, Guangzhou, Guangdong, China

17.50-18.00            ORAL 140   [POSTER 445 ]
Higher ambient temperature contributes to extrinsic skin aging
N. Singh, S. Grether-Beck, T. Schikowski, J. Krutmann
IUF Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany

Innate Immunity, Microbiology, and Microbiome 1
Room: Room D  (Ohgi) – 4F (south tower)
Chairs: Tatsuyoshi Kawamura, Heidi Kong, Anna Balato

15.30-15.40            ORAL 141   [POSTER 943 ]
Loss of both host-derived antimicrobial peptides and bacteriocin-producing commensals enables survival of Staphylococcus aureus on Th2-inflamed skin
T. Nakatsuji, S. Brinton, K. Cavagnero, T. Dokoshi, A. O’Neill, R. L. Gallo
Dermatology, University of California San Diego, La Jolla, California, United States

15.40-15.50            ORAL 142   [POSTER 950 ]
Epicutaneous staphylococcus aureus exposure triggers lung inflammation via epithelia-intrinsic IL-36R signaling
S. Nolan, Y. Saito, D. Dikeman, C. Pontaza, M. Ahmadi, C. Youn, J. Zhang, N. Archer
Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

15.50-16.00            ORAL 143   [POSTER 933  ]
Staphylococcus aureus reversibly regulates Agr quorum sensing to cause an outbreak in a hospital
Y. Yamazaki1, H. Takahashi2, A. Takaya3, Y. Matsuoka-Nakamura1, 4, M. Fujimoto1
1Dermatology, Graduate School of Medicine, Osaka University, Suita, Japan, 2Medical Mycology Research Center, Chiba, Japan, 3Natural Products Chemistry, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan, 4Cutaneous Allergy and Host Defense, Immunology Frontier Research Center, Suita, Japan

16.00-16.10            ORAL 144   [POSTER 906 ]
A novel IL-31-generating mechanism in atopic dermatitis: essential roles of macrophages in cooperation with basophils, thymic stromal lymphopoietin and periostin
T. Hashimoto, T. Satoh
Dermatology, Boei Ika Daigakko, Tokorozawa, Saitama, Japan

16.10-16.20            ORAL 145   [POSTER 974 ]
Decreased epidermal thickening by imiquimod in mice with conditional aryl hydrocarbon receptor ablation in langerhans cells: A potential role of autophagy by dysregulated AhR activation in psoriasis
C. Hong1C. Lee2
1Dermatology, National Yang Ming Chiao Tung University, Taipei, Taiwan, 2Dermatology, Chang Gung Memorial Hospital Kaohsiung Branch, Kaohsiung, Taiwan

16.20-16.30            ORAL 146   [POSTER 963 ]
Linear ubiquitin chain assembly complex (LUBAC) is involved in the development of murine imiquimod (IMQ)-induced and IL-23-induced psoriasis models
K. I. Kosaka1, S. Nakamizo1, G. Egawa1, K. Iwai2, K. Kabashima1
1Departments of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2Department of Molecular and Cellular Physiology, Kyoto University Graduate School of Medicine, Kyoto, Japan

16.30-16.40            ORAL 147   [POSTER 968 ]
A role for immunity to the microbiota in nerve overgrowth display in psoriasis skin
J. Delaleu2, 1, M. Nagai1, L. Sun1, N. Bouladoux1, I. Gribonika1, D. Corral1, A. Wells1, P. Kulalert1, V. Link1, M. Enamorado1, Y. Belkaid1
1LHIM, National Institutes of Health, Bethesda, Maryland, United States, 2Hopital Saint Louis, Dermatology Department, Universite Paris Cite, Paris, Île-de-France, France

16.40-16.50            ORAL 148   [POSTER 958 ]
Diversely polarized macrophage populations contribute to distinct manifestations of human cutaneous graft-versus-host disease
J. Strobl1, 2, 3, L. Gail3, 1, L. Krecu1, S. Mahdad2, L. Kleissl1, P. Wohlfarth4, H. Knaus4, W. Rabitsch4, M. Haniffa2, 5, G. Stary1, 3
1Department of Dermatology, Medizinische Universitat Wien, Wien, Austria, 2Wellcome Sanger Institute, Hinxton, Cambridgeshire, United Kingdom, 3CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria, 4Bone Marrow Transplantation, Medizinische Universitat Wien Universitatsklinik fur Innere Medizin I, Wien, Austria, 5Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne, Tyne and Wear, United Kingdom

16.50-17.00           ORAL 149   [POSTER 1005]
Low levels of IL-13 are constitutively produced in healthy skin and locally imprint a pro-type 2 immune response
J. Mayer1, 2, K. Hilligan2, 4, D. Eccles2, S. Old2, R. Domingues3, M. Hepworth3, O. Lamiable2, F. Ronchese2
1Department of Dermatology and Allergology, Philipps-Universitat Marburg Fachbereich Medizin, Marburg, Germany, 2Malaghan Institute of Medical Research, Wellington, New Zealand, 3The University of Manchester, Manchester, United Kingdom, 4National Institutes of Health, Bethesda, Maryland, United States

17.00-17.10           ORAL 150   [POSTER 925 ]
Peripheral sensory neurons contribute to dermatitis induced by staphylococcus aureus cell wall components via the migration of basophils
H. Irie1, C. Nakashima2, A. Otsuka2, Y. Ishida1, K. Kabashima1
1Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Kyoto, Japan, 2Dermatology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan

17.10-17.20           ORAL 151   [POSTER 948 ]
The topical TLR8 agonist resiquimod restores defective nucleotide sensing in CTCL
C. Chen1, N. Smith2, C. Villani2, P. Chaskar3, J. Krishnaswamy3, J. Teague1, A. Gehad1, L. Gray1, N. Gerard1, A. Rook4, R. Clark1
1Brigham and Women’s Hospital, Boston, Massachusetts, United States, 2Massachusetts General Hospital, Boston, Massachusetts, United States, 3Galderma SA, Lausanne, Switzerland, 4University of Pennsylvania, Philadelphia, Pennsylvania, United States

17.20-17.30           ORAL 152   [POSTER 1028 ]
Cathelicidin peptide LL37 complexed to dsRNA induces the release of interleukin-36γ from human primary keratinocytes
J. Keller1, 4, J. Danis2, E. Girousi1, 4, J. Börold1, 4, M. Szell2, L. E. French3, T. M. Kündig1, 4, M. Mellett1, 4
1Dermatology, UniversitatsSpital Zurich, Zurich, Switzerland, 2Dermatological Research Group, Szegedi Tudomanyegyetem, Szeged, Csongrád, Hungary, 3Dermatology, Ludwig-Maximilians-Universitat Munchen Medizinische Fakultat, Munchen, Bayern, Germany, 4Universitat Zurich Medizinische Fakultat, Zurich, ZH, Switzerland

17.30-17.40            ORAL 153   [POSTER 980 ]
Demodex mites reveal an unanticipated expansion of innate lymphoid-like cells in immunodeficient mice
E. Arouge1, A. Subramanian1, A. Schroeder2, V. Cortez2, C. O’Leary3R. R. Ricardo-Gonzalez1, 4, 5
1Dermatology, University of California San Francisco, San Francisco, California, United States, 2University of California San Francisco Department of Medicine, San Francisco, California, United States, 3Pediatrics, University of Wisconsin-Madison, Madison, Wisconsin, United States, 4Microbiology and Immunology, University of California San Francisco, San Francisco, California, United States, 5Chan Zuckerberg Biohub, San Francisco, California, United States

17.40-17.50            ORAL 154   [POSTER 937 ]
Disruption of the innate lymphoid cell network alters the hair cycle during induced anagen
K. Sakamoto1, 2, O. Ayush1, S. Jin3, 1, S. Goel1, A. Sekiguchi1, T. Honda2, K. Nagao1
1Dermatology Branch, NIAMS, National Institutes of Health, Bethesda, Maryland, United States, 2Dermatology, Hamamatsu Ika Daigaku, Hamamatsu, Shizuoka, Japan, 3Dermatology, Seoul National University, Gwanak-gu, Seoul, Korea (the Republic of)

17.50-18.00           ORAL 155   [POSTER 975 ]
Skin inflammation disrupts intestinal antimicrobial activity and the gut microbiome
T. Dokoshi1, G. Rahman1, K. Cavagnero1, S. Brinton1, H. Schwarz1, Y. Nakamura1, Y. Chen1, N. Salzman2, R. Knight1, R. L. Gallo1
1University of California San Diego, La Jolla, California, United States, 2Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Pharmacology and Drug Development
Room
: Room E (Moonlight) – 43F (main tower)
Chairs: Riichiro Abe, Brian Capell, Su Lwin

15.30-15.40            ORAL 156   [POSTER 1064 ]
Desmoglein 2 is a safe and universal CAR-T cell therapy target in solid cancers
R. D. Carlson1, S. A. Waldman1, M. G. Mahoney2, A. E. Snook1
1Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States, 2Dermatology & Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States

15.40-15.50            ORAL 157   [POSTER 1109 ]
First-in-class oral peptide systemically targeting the IL-23 pathway
A. Fourie1, X. Cheng2, L. Chang1, C. Greving1, A. Patrick1, B. Knight1, D. Polidori1R. Patch1, A. Bhandari2, D. Liu2, K. Huie2, S. Li2, M. Rodriguez1, A. Kannan1, J. Sherlock1, N. Modi2
1Janssen Research and Development LLC, Raritan, New Jersey, United States, 2Protagonist Therapeutics Inc, Newark, California, United States

15.50-16.00            ORAL 158   [POSTER 1060 ]
IMG-008, a potent anti-human IL-36R antagonistic antibody, inhibits IL-36R-mediated inflammation
R. Lei1, P. Fan1, M. Zhang1, Y. Wang1, C. Guo1, J. Wang2
1Inmagene Biopharmaceuticals (Hangzhou) Co., Ltd., Hangzhou, Zhejiang, China, 2Inmagene LLC, San Diego, California, United States

16.00-16.10            ORAL 159   [POSTER 1065 ]
The topical AhR agonist tapinarof has broad in vivo immunosuppressive and immunomodulatory effects in human skin grafted mice
G. Brito, A. Gehad, J. Teague, C. Chen, W. Crisler, L. Gray, I. Kim, R. Clark
Brigham and Women’s Hospital, Boston, Massachusetts, United States

16.10-16.20            ORAL 160   [POSTER 1075 ]
Topical application of activator protein-1 inhibitor T-5224 suppresses inflammation and improves skin barrier function in atopic dermatitis
M. Sasakura1, H. Urakami1, K. Tachibana1, K. Ikeda1, D. Ennishi2, S. Tomida2, S. Morizane1
1Department of Dermatology, Okayama Daigaku Daigakuin Ishiyakugaku Sogo Kenkyuka, Okayama, Japan, 2Center for Comprehensive Genomic Medicine, Okayama Daigaku Byoin, Okayama, Japan

16.20-16.30            ORAL 161   [POSTER 1104  ]
Novel and selective TRPV3 inhibitors as new potential treatments for keratodermas and itch
E. Brener1, T. Mashriki1, M. McGrath2, L. Marchal2, E. Ella1, M. Moran1, S. Leibman Barak1, B. Vaisman1, D. Terkieltaub1, N. Schutz1, A. Hovnanian2, L. Braiman1
1Kamari Pharma Ltd., Ness Ziona, Israel, 2Institut Imagine Institut des Maladies Genetiques, Paris, Île-de-France, France

16.30-16.40            ORAL 162   [POSTER 1111 ]
Topical γ-linolenic acid restores skin barrier dysfunction and ameliorates atopic dermatitis in hairless mice
M. Fujii1, S. Ohya1, 2, T. Nabe1, 3
1Pharmacology, Kyoto Yakka Daigaku, Kyoto, Japan, 2Pharmacology, Nagoya Shiritsu Daigaku, Nagoya, Aichi, Japan, 3Immunopharmacology, Setsunan Daigaku, Neyagawa, Osaka, Japan

16.40-16.50            ORAL 163   [POSTER 1101 ]
Tapinarof, a therapeutic AHR-modulating agent, induces semaphorin 3A production via NRF2 in human keratinocytes: Implications for atopic dermatitis
G. Tsuji1, A. Takai-Yumine1, M. Takemura1, K. Yamamura1, T. Ito2, M. Kido-Nakahara2, T. Nakahara1, 2
1Research and Clinical Center for Yusho and Dioxin, Kyushu Daigaku Byoin, Fukuoka, Japan, 2Dermatology, Kyushu Daigaku Igakubu Daigakuin Igakukei Gakufu Daigakuin Igaku Kenkyuin, Fukuoka, Japan

16.50-17.00            ORAL 164   [POSTER 1099 ]
Rational development of JAK1-selective siRNA therapeutics for the treatment of autoimmune skin diseases
Q. Tang1, 2, H. Fakih2, M. Zain Ul Abideen2, K. Afshari1, K. Gross2, J. Alterman2, A. Khvorova2, J. E. Harris1
1Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States, 2RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States

17.00-17.10            ORAL 165   [POSTER 1078 ]
Topical administration of MDI1228, a novel pan-JAK inhibitor, effectively suppresses the development of skin inflammation in mice
Y. Liu, M. Yin, Y. Yang, L. Zhang
School of Pharmaceutical Science, Xiamen University, Xiamen, Fujian, China

17.10-17.20            ORAL 166   [POSTER 1116 ]
Novel androgen receptor degrader for androgenetic alopecia (AGA) application
C. Chou, C. Liu, P. Liu, P. Cheng, H. Chen, K. Chen, C. Lin
AnHorn Medicines Co., Ltd., Taipei, Taiwan

17.20-17.30            ORAL 167   [POSTER 1069 ]
Fate induction in CD8 chimeric antigen receptor T cells through asymmetric cell division
C. Ellebrecht1, 2C. Lee1, 2, A. R. Kelly2, 3, C. Berry1, 2, S. Oh1, 2, R. O’Connor2, 3, A. Payne1, 2
1Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States, 2Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States, 3Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States

17.30-17.40            ORAL 168   [POSTER 1126 ]
A pilot of a microdevice for in situ candidate drug screening in cutaneous lesions of T-cell lymphoma
K. Awh1, 2, C. J. Fay1, 2, N. LeBoeuf1, 2, O. Jonas3, C. Larocca1, 2
1Brigham and Women’s Hospital Department of Dermatology, Boston, Massachusetts, United States, 2Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 3Brigham and Women’s Hospital Department of Radiology, Boston, Massachusetts, United States

17.40-17.50            ORAL 169   [POSTER 1089  ]
Targeting right open reading frame protein kinase 3 (RIOK3) for the modulation of type III IFN in skin.
M. Diaz1, M. Diaz1, J. Kreitinger1, T. C. Bisom2, J. Lodmell3, P. Diaz1, 4
1DermaXon, Missoula, Montana, United States, 2Dept. of Chemistry and Biochemistry, University of Montana College of Humanities and Sciences, Missoula, Montana, United States, 3Division of Biological Sciences, University of Montana College of Humanities and Sciences, Missoula, Montana, United States, 4Department of Biomedical and Pharmaceutical Sciences, University of Montana College of Health, Missoula, Montana, United States

17.50-18.00            ORAL 170   [POSTER 1098 ]
Anti-inflammatory and antibacterial drug delivery nanocarriers for the topical treatment of MRSA-induced systemic and localized infections
Y. Chang1, C. Lin1, T. Huang1, 2, 3, J. Fang1, 2, 3
1Graduate Institute of Natural Products, Chang Gung University, Taoyuan, Taiwan, 2Department of Anesthesiology, Chang Gung Memorial Hospital Linkou, Taoyuan, Taiwan, 3Research Center for Food and Cosmetic Safety and Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Gueishan, Taoyuan, Taiwan

Photobiology and Skin of Color
Room:
Room F (Harmony) – 44F (main tower)
Chairs: Hee Young Kan, Raymond Konger, Andrea Szegedi

15.30-15.40            ORAL 171   [POSTER 1161 ]
UV irradiation modulates appetite and body weight through upregulating norepinephrine in mice
Q. Quan1, 2, 3, E. Kim1, 2, 3, Y. Kim1, 2, 3, S. Kim1, 2, 3, M. Chung1, 2, 3, Y. Tian1, 2, 3, C. Shin1, 2, 3, D. Lee1, 2, 3, J. Chung1, 2, 3
1Dermatology, Seoul National University College of Medicine, Seoul, Korea (the Republic of), 2Laboratory of Cutaneous Aging Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea (the Republic of), 3Institute of Human-Environment Interface Biology, Seoul National University, Seoul, Korea (the Republic of)

15.40-15.50            ORAL 172   [POSTER 1163 ]
Skin commensal bacteria modulate ultraviolet radiation-induced cytokine secretion in human keratinocytes
H. Serrage1, M. Farrar1, A. J. Mcbain1, J. Pennock1, C. Deng1, C. O’Neill1, 2
1The University of Manchester, Manchester, United Kingdom, 2Skin BioTherapeutics PLC, Newcastle, United Kingdom

15.50-16.00            ORAL 173   [POSTER 1146 ]
Mitochondrial dysfunction in xeroderma pigmentosum type A (XPA) causes UV-induced collapse of proteostasis due to lack of ATP
M. Majora, R. Bhattacharjee, S. Dangeleit, A. Rossi, J. Krutmann
IUF – Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany

16.00-16.10            ORAL 174   [POSTER 1136 ]
Xeroderma Pigmentosum: From disease modeling using CRISPR-Cas9 technology to the understanding of skin cancers pathophysiology
A. Nasrallah1, F. Kobaisi1, S. Bourgoin-Voillard2, F. Clement1, X. Gidrol1, M. Seve2, E. Sulpice1, W. Rachidi1
1Univ. Grenoble Alpes, CEA, INSERM, 38000 Grenoble, France, Grenoble, France, 2Univ. Grenoble Alpes, CNRS, TIMC U5525, EPSP 38000 Grenoble, France, Grenoble, France

16.10-16.20            ORAL 175   [POSTER 1145 ]
Evidence that microvesicle particles mediate the photosensitivity associated with xeroderma pigmentosum A deficiency
P. Manjrekar, L. R. Christian, C. Rapp, K. M. Henkels, R. Annamraju, Y. Chen, J. Travers
Pharmacology & Toxicology, Wright State University Boonshoft School of Medicine, Dayton, Ohio, United States

16.20-16.30            ORAL 176   [POSTER 1166 ]
Kinome siRNA screening for the treatment of the XPC cancer-prone disease
F. Kobaisi1, E. Sulpice2, A. Nasrallah1, X. Gidrol2W. Rachidi1
1Universite Grenoble Alpes, Saint-Martin-d’Heres, Auvergne-Rhône-Alpes , France, 2IRIG, Commissariat a l’energie atomique et aux energies alternatives Siege administratif, Grenoble, France

16.30-16.40            ORAL 177   [POSTER 1168 ]
Neutrophil cytokines and NETs mediate skin and kidney inflammation in lupus flare under UVB irradiation
X. Lyu1, M. Li1, P. Zhang2, W. Wei1, V. P. Werth3M. Liu3
1Tianjin Medical University, Tianjin, China, 2Beaumont Health, Royal oak, Michigan, United States, 3University of Pennsylvania, Philadelphia, Pennsylvania, United States

16.40-16.50            ORAL 178   [POSTER 1156 ]
Single-cell RNA sequencing of photoaged skin reveals SLC46A2 as potential cGAMP transporter in keratinocytes
D. J. Kim1, A. Billi3, A. Chien2, G. J. Fisher3, J. J. Voorhees3, J. Gudjonsson3, S. Kang2
1Yale School of Medicine, New Haven, Connecticut, United States, 2Johns Hopkins Medicine, Baltimore, Maryland, United States, 3University of Michigan, Ann Arbor, Michigan, United States

16.50-17.00            ORAL 179   [POSTER 1291 ]
Tralokinumab improves signs, symptoms, and key biomarkers in patients of different racial subgroups with atopic dermatitis
A. Alexis1, A. Blauvelt2, A. Armstrong3, L. Kircik4, K. Kabashima5, N. Katoh6, B. Esdaile7, M. Røpke8, A. Kurbasic8, S. Schneider9E. Guttman-Yassky4
1Weill Cornell Medicine, New York, New York, United States, 2Oregon Medical Research Center, Portland, Oregon, United States, 3University of Southern California Keck School of Medicine, Los Angeles, California, United States, 4Icahn School of Medicine at Mount Sinai, New York, New York, United States, 5Graduate School of Medicine, Kyoto University, Kyoto, Japan, 6Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan, 7Whittington Health NHS Trust, London, United Kingdom, 8LEO Pharma A/S, Ballerup, Hovedstaden, Denmark, 9LEO Pharma Inc, Madison, New Jersey, United States

17.00-17.10            ORAL 180   [POSTER 1301 ]
Polyamines: Novel regulators of human epidermal pigmentation
A. Sridharan1, Z. Lim1, K. Igarashi4, A. N. Tan3, S. T. Thng2L. A. Vardy1
1Agency for Science Technology and Research, Singapore, Singapore, 2National Skin Centre, Singapore, Singapore, 3Nanyang Technological University, Singapore, Singapore, 4Chiba Daigaku Daigakuin Igaku Kenkyuin Igakubu, Chiba, Japan

17.10-17.20            ORAL 181   [POSTER 1305 ]
Involucrin/ck1e/vitamin D receptor regulatory axis underlies evolution of human epidermis out of Africa
A. R. Hicks1, 2, A. D. Schmidt3, M. Mathyer3C. de Guzman Strong1, 2, 3
1Dermatology, Henry Ford Health System, Detroit, Michigan, United States, 2Medicine, Michigan State University College of Human Medicine, East Lansing, Michigan, United States, 3Medicine, Washington University in St Louis School of Medicine, St Louis, Missouri, United States

17.20-17.30            ORAL 182   [POSTER 1318 ]
Racial differences in the skin microbiome of cutaneous T cell lymphoma patients
L. Ayanruoh1, M. J. Hooper1, T. Griffin1, G. Enriquez2, J. Choi1, J. Guitart1, M. Burns2, X. Zhou1
1Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States, 2Biology, Loyola University Chicago, Chicago, Illinois, United States

17.30-17.40            ORAL 183   [POSTER 1320 ]
Keloid transcriptome analysis: ZNF469 more than meets the eye
S. Hamzehlou1, C. Xing2, D. Glass1, 2
1Dermatology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States, 2McDermott Center for Human Growth and Development, The University of Texas Southwestern Medical Center, Dallas, Texas, United States

17.40-17.50            ORAL 184   [POSTER 1294 ]
Proteomic profiling of CCCA reveals unique inflammatory and metabolic protein signature
A. Gadre1, T. Dyson2, C. Aguh1
1Dept of Dermatology, Johns Hopkins Medicine, Baltimore, Maryland, United States, 2Eastern Virginia Medical School, Norfolk, Virginia, United States

17.50-18.00            ORAL 185   [POSTER 1312 ]
Heterogeneities in proteomic profiles among African American and East African patients with atopic dermatitis
D. Liu1, E. Del Duca1, Y. Renert-Yuval2, C. Lang3, H. Kaderbhai4, G. Semango4, M. Brüggen3, J. Krueger2, J. Masenga4, E. Guttman-Yassky1
1Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, United States, 2Laboratory of Investigative Dermatology, The Rockefeller University, New York, New York, United States, 3Dermatology, UniversitatsSpital Zurich, Zurich, Switzerland, 4Dermatology, Regional Dermatology Training Centre, Moshi, Tanzania, United Republic of

Skin, Appendages and Stem Cell Biology
Room: Room G (Takao) – 42F (main tower)
Chairs: Ohsang Kwon, Sunny Wong, Carien Niessen

15.30-15.40            ORAL 186   [POSTER 1390 ]
Active hair growth is fuelled by conveyor-belt like differentiation of germinative layer cells
K. Annusver1, D. Pereira2, D. Fernandex1, B. Robert3, J. Nicolas3, M. Kasper1, I. Sequeira2
1Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden, 2Queen Mary University of London Barts and The London School of Medicine and Dentistry, London, United Kingdom, 3Institut Pasteur, Paris, Île-de-France, France

15.40-15.50            ORAL 187   [POSTER 1322 ]
A non-cell autonomous dermal hedgehog signaling mechanism for follicular neoplasia and induction.
S. Li1, 2, A. Shah2, E. Sanchez-Ortiz2, N. Liu2, E. Olson2
1Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States, 2Molecular Biology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States

15.50-16.00            ORAL 188   [POSTER 1401 ]
ΔNp63 regulates homeostasis, stemness, and suppression of inflammation in the adult epidermis
C. Eyermann1, X. Chen1, O. Somuncu1, A. Joukov2, J. Chen1E. Alexandrova1
1Stony Brook University, Stony Brook, New York, United States, 2Ward Melville High School, East Setauket, New York, United States

16.00-16.10            ORAL 189   [POSTER 1439 ]
Development of a complex skin organ in human induced pluripotent stem cell-derived organoids
A. Shafiee1, 2, 3, J. Sun1, I. Ahmed1, J. Brown2, 3, K. Khosrotehrani1
1The University of Queensland, Brisbane, Queensland, Australia, 2Herston Biofabrication Institute, Metro North Hospital and Health Service, Brisbane, Queensland, Australia, 3Royal Brisbane and Women’s Hospital, Metro North Hospital and Health Service, Brisbane, Queensland, Australia

16.10-16.20            ORAL 190   [POSTER 1426 ]
Deletion of hoxc13 in frogs reveals key steps in the molecular evolution of cornified skin appendages
A. P. Sachslehner1, M. Carron2, 3, S. Demuynck2, E. De Baere3, K. Vleminckx2L. Eckhart1
1Department of Dermatology, Medical University of Vienna, Vienna, Austria, 2Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium, 3Department of Biomolecular Medicine, Ghent University, Ghent, Belgium

16.20-16.30            ORAL 191   [POSTER 1397 ]
LSD1 is critical for epidermal development and skin barrier formation
N. Kuprasertkul, S. Egolf, C. Magahis, C. D’souza, J. Zou, D. Brennan-Crispi, B. C. Capell
University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States

16.30-16.40            ORAL 192   [POSTER 1438 ]
KLF4 maintains hair follicle stem cell quiescence
M. Xu1, D. Moran2, K. M. Szigety2, X. Zhu1, S. Millar1
1Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai Black Family Stem Cell Institute, New York, New York, United States, 2Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States

16.40-16.50            ORAL 193   [POSTER 1418 ]
Characterization of ectomesenchyme as an origin of epidermal stem cells
A. Miura1, Y. Kobayashi1, Y. Hirose1, A. Yamanishi1, Y. Ouchi2, R. Yamamoto2, T. Kitayama2, E. Takaki2, T. Shimbo2, K. Tamai1
1Stem Cell Therapy Science, Osaka University Graduate School of Medicine, Suita-city, Osaka, Japan, 2StemRIM Institute of Regeneration-Inducing Medicine, Osaka University, Suita-city, Osaka, Japan

16.50-17.00            ORAL 194   [POSTER 1376 ]
A multi-scale spatial atlas of human skin links cancer cell states to site of origin
C. Ganier1, B. Du-Harpur1, G. Herrera-Oropeza8, P. Mazin2, A. Predeus2, J. Gabriel1, N. Harun1, M. Blakeley1, J. Darrigrand1, A. Haiser1, S. Wyles3, T. J. Shaw4, S. Teichmann2, M. Haniffa2, 5, F. M. Watt1, 6, M. Lynch1, 7
1Centre for Gene Therapy and Regenerative Medecine, Guy’s Hospital, King’s College London Faculty of Life Sciences and Medicine, London, United Kingdom, 2Wellcome Sanger Institute, Hinxton, Cambridgeshire, United Kingdom, 3Department of Dermatology, Mayo Clinic Minnesota, Rochester, Minnesota, United States, 4Centre for Inflammation Biology & Cancer Immunology, King’s College London School of Medical Education, London, United Kingdom, 5Department of Dermatology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom, 6Gesellschaft zur Forderung der Lebenswissenschaften Heidelberg GmbH, Heidelberg, Baden-Württemberg, Germany, 7St John’s Institute of Dermatology, King’s College London Faculty of Life Sciences and Medicine, London, United Kingdom, 8King’s College London Institute of Psychiatry Psychology and Neuroscience, London, United Kingdom

17.00-17.10            ORAL 195   [POSTER 1352 ]
Ectopic fibroblasts to modify skin identity
S. S. Lee1, P. Derr2, E. Dare1, E. Sweren1, K. Derr2, B. Hardesty1, C. Wang1, A. Willis1, J. Chen3, J. Vuillier1, J. Du1, M. Daskam1, J. Wool1, A. Ruci1, V. . Wang1, C. Lee1, S. Iyengar1, D. Cho1, E. Martinez-Pena1, S. Lee1, X. He1, S. Kim1, Y. Chen3, S. Kang1, L. A. Garza1
1Dermatology, Johns Hopkins Medicine, Baltimore, Maryland, United States, 2National Center for Advancing Translational Sciences, Rockville, Maryland, United States, 3Johns Hopkins University Whiting School of Engineering, Baltimore, Maryland, United States

17.10-17.20            ORAL 196   [POSTER 1381 ]
Investigating the role of Mef2c in hair follicle cycling
T. Tien1, 3, N. Pantelireis1, 2, C. Higgins2, C. Clavel1, 3
1A*STAR Skin Research Labs, Agency for Science Technology and Research, Singapore, Singapore, 2Imperial College London Department of Bioengineering, London, London, United Kingdom, 3Lee Kong Chian School of Medicine, Singapore, Singapore

17.20-17.30            ORAL 197   [POSTER 1443 ]
Skin regional specificity and the regulation of HoxC gene cluster
S. Hsieh Li1, 2, Y. Liang1, R. Widelitz1, L. Andersson3, P. Wu1C. Chuong1
1Pathology, University of Southern California, Los Angeles, California, United States, 2Biochemistry, National Defense Medical Center, Taipei, Taiwan, 3Medical Biochemistry and Microbiology, Uppsala universitet Medicinska fakulteten, Uppsala, Sweden

17.30-17.40            ORAL 198   [POSTER 1360 ]
Fate tracing of DNA-damaged hair follicle stem cells and their seno-differentiation clearance out of the niche
M. Miranda, H. Matsumura, K. Asakawa, T. Kato, Y. Muroyama, M. Higa, L. Tan, Y. Kawamura, E. K. Nishimura
Division of Aging and Regeneration, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

17.40-17.50            ORAL 199   [POSTER 1383 ]
Dermal adipogenesis is regulated by an interplay between the WNT-β-catenin and IL1 signaling pathways during skin development and regeneration
X. Zhang3, L. Sun3, S. Wu3, W. Liu3, Y. Liu3, F. Li1, Q. Yao3, J. Li3, J. Huang2, C. Ji2, R. L. Gallo1, L. Zhang3
1Department of Dermatology, University of California San Diego, La Jolla, California, United States, 2Department of Dermatology, First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China, 3State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, China

17.50-18.00            ORAL  200   [POSTER 1356 ]
Wound memory predisposes to tumorigenesis
M. Watanabe1, 2, 5, C. Levralevron1, 2, V. Proserpio1, 2, 3, G. Piacenti1, 2, A. Lauria1, 2, 3, S. Kaltenbach4, A. Tamburrini1, 2, 3, K. Natsuga5, T. Hagai4, S. Oliviero1, 2, 3, G. Donati1, 2
1Life Sciences and Systems Biology, Universita degli Studi di Torino, Torino, Piemonte, Italy, 2Molecular Biotechnology Center, Universita degli Studi di Torino, Torino, Piemonte, Italy, 3Italian Institute for Genomic Medicine, Torino, Piemonte, Italy, 4George S Wise Faculty of Life Sciences, Tel Aviv University The Shmunis School of Biomedicine and Cancer Research, Tel Aviv, Israel, 5Dermatology, Hokkaido Daigaku Daigakuin Igaku Kenkyuin, Sapporo, Hokkaido, Japan

ePoster Stage 1: Artificial Intelligence, Image Analysis, and Translational Studies/Pigmentation & Melanoma
Chairs: Kazutoshi Harada, Jeffrey Cheng

ePoster Stage 2:  Innate Immunity, Microbiology, & Microbiome I & II 
Chairs: Yu Sawada, Tamia A. Harris-Tryon, Jeremy di Domizio

ePoster Stage 3: Cell-Cell Interactions in the Skin/Epidermal Structure and Barrier Function
Chairs: Satoru Shinkuma, Takashi Matsushita, Adam Glick

ePoster Stage 4: Pharmacology and Drug Development/Clinical Research, Interventional Research, and Sociobehavioral and Health Services Research 
Chairs: Toshifumi Nomura, Dong Hun Lee, Mackenzie Wehner, Marta Bertolini

ePoster Stage 5: Late-Breaking Abstracts
Chairs: Akihiko Uchiyama, Eugene Semenov

Find the detailed e-poster sessions HERE

Entrance fees: $25
Purchase your ticket through the regular registration link

Venue: CÉ LA VI TOKYO, Tokyu Plaza Shibuya 18th floor, 1-2-3 Dogenzaka, Shibuya-ku, Tokyo
Google Maps / Apple Maps

Saturday 13 May 2023

Day Four

Symposium for Silver Sponsor

Nov division, TOKIWA Pharmaceutical Co., Ltd Symposium
Title: New Technology Opens the Future of Dermatology
Room: Room A (Concord Ballroom) – 5F  (main tower)
Boxed breakfast provided

PROGRAM:
Chairs: Shinichi Sato and Manabu Fujimoto

What can we learn from Fli1-deficient mice, new animal models of systemic sclerosis?
Yoshihide Asano

How to utilize genomics in dermatology
Yukinori Okada

 

Symposium for Silver Sponsor

Amgen Symposium
Title: TBA
Room: Room B (Eminence Hall) – 5F (south tower)
Boxed breakfast provided

PROGRAM:
Chairs: Daisuke Tsuruta,and Hiroyuki Murota

The possible role of psoriatic skin inflammation for the development of systemic organ dysfunction and osteoporosis
Yu Sawada

Mitochondrial metabolism in psoriatic T cells
Rei Watanabe

Symposium for Silver Sponsor

Sato Pharmaceutical/Eisai Co Symposium
Title: Fosravuconazole, an Oral Antifungal Agent for the Treatment of Onychomycosis: Basic Characteristics and Clinical Effects
Room: Room C (Nishiki) – 4F (south tower)
Boxed breakfast provided

PROGRAM:
Chairs: Yoshiki Miyachi, and Nikolas Haass

Mycological characteristics of the causative agents of onychomycosis
Takashi Sugita

Key points for achieving complete cure in the treatment of onychomycosis
Taisuke Ito

Symposium for Silver Sponsor

Nobelpharma Symposium
Title: Therapeutic Effects of Topical Sirolimus on Skin Lesions in Tuberous Sclerosis: Including clinical collaboration
Room: Room D (Ohgi) 4F (south tower)
Boxed breakfast provided

PROGRAM:
Chair: Masatoshi Jinnin
Speaker: Sei-ichiro Motegi

Symposium for Silver Sponsor

Incyte Symposium
Title
: Vitiligo Pathophysiology and Emerging Treatments
Room: Room E (Moonlight) – 43F (main tower)

PROGRAM:
Welcome and introduction
Jim Lee

Vitiligo pathophysiology and emerging treatments
Mehdi Rashighi Firoozabadi

Panel Discussion and Audience Q & A

Room: Room A (Concord Ballroom) – 5F  (main tower)
Chairs: Manabu Fujimoto, Luis Garza, Julien Seneschal

08.10 AM-08.22            ORAL 201   [POSTER 1405 ]
Cellular and molecular characterization of sebaceous gland self-renewal and regeneration following complete genetic ablation
N. A. Veniaminova1, Y. Jia2, A. Hartigan1, T. Huyge1, S. Tsai1, M. A. Grachtchouk1, S. Nakagawa3, A. Dlugosz1, 4, S. Atwood2, S. Wong1, 4
1Department of Dermatology, University of Michigan, Ann Arbor, Michigan, United States, 2Department of Developmental and Cell Biology, University of California Irvine, Irvine, California, United States, 3Department of Pathology, University of Michigan, Ann Arbor, Michigan, United States, 4Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan, United States

08.22 AM-08.34            ORAL 202   [POSTER 469 ]
Evidence of a causal relationship between stroke and psoriasis
R. Ramessur, J. Saklatvala, J. Barker, N. Dand, M. Simpson, C. Smith
King’s College London, London, United Kingdom

08.34 AM-08.46            ORAL 203   [POSTER 668]
Prevention of cardiovascular disease and mortality in patients with psoriasis or psoriatic arthritis (CP3) study: Preliminary results
A. Neopaney5, S. Wang5, D. B. Shin5, R. Fitzsimmons5, S. Baez5, A. Armstrong1, J. Barbieri2, R. Beidas4, M. Garshick3, N. Mehta6, A. Ogdie5, J. Gelfand5
1University of Southern California, Los Angeles, California, United States, 2Harvard University, Cambridge, Massachusetts, United States, 3NYU Langone Health, New York, New York, United States, 4Northwestern University, Chicago, Illinois, United States, 5University of Pennsylvania, Philadelphia, Pennsylvania, United States, 6George Washington University, Washington, District of Columbia, United States

08.46 AM-08.58            ORAL 204   [POSTER 851  ]
RNA therapy for congenital melanocytic naevi
D. Bryant1, 3, R. Maeshima3, W. Baird3, A. Sauvadet1, 3, C. Demetriou3, D. Zecchin1, 3, S. Barberan-Martin1, 3, A. Pittman5, S. Polubothu3, 2, L. Larue4, S. L. Hart3, V. A. Kinsler1, 2, 3
1Mosaicism and Precision Medicine Lab, Francis Crick Institute, London, United Kingdom, 2Great Ormond Street Hospital, London, United Kingdom, 3UCL Institute of Child Health, London, United Kingdom, 4Institut Curie, Orsay, France, 5St George’s University of London, London, United Kingdom

08.58-09.10            ORAL 205   [POSTER 1208 ]
Lactate and its induced EGR1 are novel key factors that determines the inflamed or non-inflamed tumor status
H. Kanemaru1, 2, Y. Mizukami1, A. Kaneko1, T. Kimura1, H. Kuriyama1, I. Kajihara1, S. Fukushima1
1Department of Dermatology and Plastic Surgery, Kumamoto University, Kumamoto, Japan, 2Department of Life Sciences, Imperial College London, London, United Kingdom

The Evolution of Human Skin Pigmentation as a Long and Complex Biocultural Phenomenon
Nina Jablonski

Room: Room A (Concord Ballroom) – 5F  (main tower)
Chair: Tissa Hata

Skin myeloid cell heterogeneity
Florent Ginhoux

Room: Room A (Concord Ballroom) – 5F  (main tower)
Chair: Hervé Bachelez

Symposium for Platinum Sponsor

Novartis Pharma K.K. Symposium
Title: Reimagining Immuno-dermatology
Room: Room A (Concord Ballroom) – 5F  (main tower)

PROGRAM:

Reimaging Urticaria
Chair: Kenji Kabashima
Speaker: Marcus Maurer

Reimagining Melanoma-2023
Chair: Russell Hall
Speaker: Victoria Atkinson

Reimagining Memory of Skin Inflammation
Chair: Yoshiki Tokura
Speaker: Liv Eidsmo

 

Symposium for Gold Sponsors

UCB Symposium
Title: Spotlight on Psoriasis: New Perspectives on Therapy and Pathology
Room: Room A (Concord Ballroom) – 5F  (main tower)
Boxed lunch provided

PROGRAM:

Chairs: Akimichi Morita, and Christopher Griffiths

Painting a Picture: The Therapeutic Landscape of Psoriasis
Yayoi Tada

Straight Up: How Does the ‘Cytokine Cocktail’ Drive the Progression of Psoriasis?
James Krueger

Symposium for Gold Sponsors

Janssen Pharmaceutical/Taiho Pharmaceutical Symposium
Title: Characteristics of Palmoplantar Pustulosis 
Room: Room B (Eminence Hall) – 5F (south tower)
Boxed lunch provided

PROGRAM:
Chairs: Kazumitsu Sugiura, and Riichiro Abe

Characteristics of Japanese patients with palmoplantar pustulosis
Masamoto Murakami

Clinical characteristics and treatment status of palmoplantar pustulosis
Mitsumasa Kishimoto

Symposium for Gold Sponsors

Mitsubishi Tanabe Pharma/Teikoku Seiyaku Symposium
Title: Itch Caused by Common Skin Disease
Room: Room C (Nishiki) – 4F (south tower)
Boxed lunch provided

PROGRAM:
Chair: Shinichi Sato

Mechanism and therapeutics of itch in atopic dermatitis
Saeko Nakajima

Pruritus in Urticaria Management
Naoko Inomata

Symposium for Gold Sponsors

The Estée Lauder Companies Inc. Symposium
Title: Skin Barrier Function and Approaches for Improving Innate Hydration of Skin
Room: Room D (Ohgi) 4F (south tower)
Boxed lunch provided

PROGRAM:
Chair: Kenji Kabashima

Moisturize your skin by the skin innate hydration
Teruki Dainichi

New moisturizing ingredient for improving skin’s innate hydration – Rice Power™ #11α
Yuichi Miyoshi

In vitro/in vivo proven superior hydration benefits of Rice Power™ #11α containing formulations
Richard Cao

Symposium for Gold Sponsors

SUN Pharma Symposium
Title
: How to Apply Genetic Information to Autoimmune Research
Room: Room E (Moonlight) – 43F (main tower)
Boxed lunch provided

PROGRAM:
Chair: Shinji Shimada

How to Apply Genetic Information to Autoimmune Research
Speaker: Kazuhiko Yamamoto

Symposium for Gold Sponsors

Procter & Gamble Symposium
Title: A Novel Approach in Understanding Skin Leveraging Spatial Biology
Room: Room F (Harmony) – 44F (main tower)
Boxed lunch provided

PROGRAM:
In vivo skin imaging: towards non-invasive skin biopsy
Gyohei Egawa

Spatial Analysis via Single-Cell RNA Sequencing: Galactomyces Ferment Filtrate’s Efficacy on Human Epidermis
Satoshi Nakamizo

Cell-Cell Adhesion of the Skin
Room: Room A (Concord Ballroom) – 5F  (main tower)
Chairs: Tetsuya Honda, Maria Morasso, Rachel Watson

13.15-13.25            ORAL 206   [POSTER 355 ]
Sensory neuronal STAT3 is critical for IL-31 receptor expression and inflammatory itch
S. Takahashi1, S. Ochiai1, T. Okada1, 2
1Rikagaku Kenkyujo Yokohama Campus, Yokohama, Kanagawa, Japan, 2Yokohama Shiritsu Daigaku, Yokohama, Kanagawa, Japan

13.25-13.35            ORAL 207   [POSTER 319 ]
Spatial transcriptomics and single-cell transcriptomics elucidates the intricate inflammatory cellular network in atopic dermatitis
Y. Mitamura1, M. Reiger2, J. Kim1, Y. Xiao1, D. Zhakparov1, B. Rückert1, P. Brunner3, D. Roqueiro4, C. Traidl-Hoffmann2, C. Akdis1
1Universitat Zurich Schweizerisches Institut fur Allergie- und Asthmaforschung, Davos, Switzerland, 2Department of Environmental Medicine, Faculty of Medicine, Universitat Augsburg, Augsburg, Bayern, Germany, 3Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, United States, 4Department of Biosystems Science and Engineering, ETH-Bereich Hochschulen, Zurich, Zürich, Switzerland

13.35-13.45            ORAL 208   [POSTER 349 ]
Propionate alleviates itch in atopic dermatitis by modulating sensory TRP channels of dorsal root ganglion
Y. Xu1, X. Yao2, W. Li1
1Department of Dermatology, Huashan Hospital Fudan University, Shanghai, China, 2Affiliated Hospital for Skin Diseases of Chinese Academy of Medical Sciences, Nanjing, Jiangsu, China

13.45-13.55            ORAL 209   [POSTER 338 ]
Extracellular matrix (ECM) remodeling in atopic dermatitis (AD) as a putative contributor to the atopic march
D. S. Wörz1, P. Graff3, T. Blimkie2, P. Panwar5, D. Brömme5, R. E. Hancock2, S. Hedtrich1, 4
1Berlin Institute of Health at Charite, Berlin, Germany, 2The University of British Columbia Centre for Microbial Diseases and Immunity Research, Vancouver, British Columbia, Canada, 3Freie Universitat Berlin Institut fur Pharmazie, Berlin, Germany, 4The University of British Columbia Faculty of Pharmaceutical Sciences, Vancouver, British Columbia, Canada, 5The University of British Columbia Faculty of Dentistry, Vancouver, British Columbia, Canada

13.55-14.05            ORAL 210   [POSTER 363 ]
Elevated expression of CCN1 in dermal fibroblasts causes accelerated dermal aging and promotes keratinocyte carcinogenesis
T. Quan, A. Kim, C. Guo, Y. Xiang, Z. Qin, Y. Liu, Y. Yan, A. Ermilov, J. J. Voorhees, A. Dlugosz, G. J. Fisher
Dermatology, University of Michigan, Ann Arbor, Michigan, United States

14.05-14.15            ORAL 211   [POSTER 351 ]
Single-cell analysis of immune system interactions in the basal cell carcinoma tumor microenvironment
Q. N. Wong, S. Atwood
Developmental and Cell Biology, University of California Irvine, Irvine, California, United States

14.15-14.25            ORAL 212   [POSTER 323 ]
Transcriptomic analysis indicates that loss of epidermal Pparg promotes TLR4 signaling and significant overlap with the NMSC transcriptome
R. L. Konger1, X. Xuei2, H. Gao2
1Pathology, Indiana University School of Medicine, Indianapolis, Indiana, United States, 2Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, United States

14.25-14.35            ORAL 213   [POSTER 359 ]
Pansclerotic morphea is characterized by type II IFN responses priming T cell – cDC2b – fibroblast crosstalk to promote fibrosis
E. Xing, F. Ma, A. Billi, M. Gharaee-Kermani, J. M. Kahlenberg, R. Wasikowski, L. Tsoi, D. Khanna, J. Gudjonsson
University of Michigan, Ann Arbor, Michigan, United States

14.35-14.45            ORAL 214   [POSTER 336 ]
NET-associated DLL4 activates notch- γ secretase signaling in macrophages and fibroblasts and promotes pro-fibrotic responses in hidradenitis suppurativa
C. Carmona-Rivera1, C. B. Oliveira1, J. Tena-Romo1, E. Patino-Martinez1, A. Woo1, A. Byrd2, G. Okoye2, M. Kaplan1
1Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, United States, 2Dermatology, Howard University College of Medicine, Washington, District of Columbia, United States

14.45-14.55            ORAL 215   [POSTER 347 ]
A machine learning analysis enables demonstration that fibroblasts mediate neutrophil recruitment during type 17 skin inflammation
K. Cavagnero, T. Dokoshi, A. O’Neill, T. Nakatsuji, F. Li, R. L. Gallo
Dermatology, University of California San Diego, La Jolla, California, United States

14.55-15.05            ORAL 216   [POSTER 327 ]
The early reactivation of resident CD8+ memory t cells depends on cross-presentation of antigen by langerhans cells in the epidermis.
N. Kamenjarin1, 2, K. Hodapp1, 2, F. Melchior1, 2, G. Harms2, 3, V. Raker4, C. Becker4, A. Brand2, 5, B. Clausen2, 5, H. Probst1, 2
1Institute of Immunology, Universitatsmedizin der Johannes Gutenberg-Universitat Mainz, Mainz, Rheinland-Pfalz, Germany, 2Research Center for Immunotherapy, Universitatsmedizin der Johannes Gutenberg-Universitat Mainz, Mainz, Rheinland-Pfalz, Germany, 3Cell Biology Unit, Universitatsmedizin der Johannes Gutenberg-Universitat Mainz, Mainz, Rheinland-Pfalz, Germany, 4Department of Dermatology, Westfalische Wilhelms-Universitat Munster, Münster, Nordrhein-Westfalen, Germany, 5Institute for Molecular Medicine, Universitatsmedizin der Johannes Gutenberg-Universitat Mainz, Mainz, Rheinland-Pfalz, Germany

15.05-15.15            ORAL 217   [POSTER 361]
p120-catenin regulates epidermal inflammation in a cadherin-dependent manner
T. Seo, H. Xu, M. Sennett, S. L. Schell, A. M. Nelson, A. P. Kowalczyk
Dermatology, Penn State College of Medicine, Hershey, Pennsylvania, United States

15.15-15.25            ORAL 218   [POSTER 373  ]
Identification of immune cell pathways in acne vs. rosacea by single-cell RNA sequencing and single-cell spatial imaging
T. H. Do1, 2, J. Perrie2, M. Pellegrini2, J. Gudjonsson3, F. Ma3, R. L. Modlin2
1Stony Brook Southampton Hospital, Southampton, New York, United States, 2University of California Los Angeles, Los Angeles, California, United States, 3University of Michigan, Ann Arbor, Michigan, United States

15.25-15.35            ORAL 219   [POSTER 350 ]
Increased LL37 in patients with psoriasis and rosacea promotes the uptake of low-density lipoprotein and development of atherosclerosis
Y. Nakamura1, N. Kulkarni1, T. Dokoshi1, E. W. Luo2, H. Alimohamadi2, G. C. Wong2, R. L. Gallo1
1Dermatology, University of California San Diego, La Jolla, California, United States, 2Bioengineering, University of California Los Angeles, Los Angeles, California, United States

15.35-15.45            ORAL 220   [POSTER 365 ]
Axon growth inhibitory molecule nogo regulates epidermal innervation by sensory neurons
A. Matsuyama, T. Okada
Center for Integrative Medical Sciences, Rikagaku Kenkyujo Yokohama Campus, Yokohama, Kanagawa, Japan

Clinical Research – Socio-behavioral and Health Services Research/Clinical Research- Interventional Research
Room:
Room B (Eminence Hall) – 5F (south tower)
Chairs: Soyun Cho, Scott Worswick, Liat Samuelov

13.15-13.25            ORAL 221   [POSTER 690 ]
Trends in topical steroids spending and potential savings: An analysis of United States medicare part D from 2011 to 2020
S. Ly1, 2, P. Manjaly1, K. Kamal1, A. Mostaghimi1
1Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts, United States, 2University of Arkansas for Medical Sciences College of Medicine, Little Rock, Arkansas, United States

13.25-13.35            ORAL 222   [POSTER 683 ]
Loneliness, stress, and discrimination in patients with and without acne: A cross-sectional study
W. Perry1, 2, S. Tushe2, H. Yeung2
1Emergency Medicine, Emory University School of Medicine, Atlanta, Georgia, United States, 2Dermatology, Emory University School of Medicine, Atlanta, Georgia, United States

13.35-13.45            ORAL 223   [POSTER 586 ]
Increase in CD8+ effector memory cells re-expressing CD45RA (TEMRA) reflects disease activity and enables early prediction of therapeutic outcome in rapidly progressive alopecia areata
R. Takahashi1, M. Kinoshita-Ise2, Y. Sato2, M. Kimishima2, M. Ohyama1, 2
1Flow Cytometry Core Facility, Kyorin University Graduate School of Medicine, Mitaka, TOKYO, Japan, 2Department of Dermatology, Kyorin University Faculty of Medicine, Mitaka, TOKYO, Japan

13.45-13.55            ORAL 224   [POSTER 689 ]
Tiktok and dermal fillers: A cross-sectional study on dermal filler-related content quality
H. de Baun1, P. E. Cerri-Droz1, S. Khan2, B. Rao2
1Stony Brook University Renaissance School of Medicine, Stony Brook, New York, United States, 2Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, United States

13.55-14.05            ORAL 225   [POSTER 646 ]
IFN-α therapy of peritoneal carcinosis induces senescence in metastatic melanoma cells
E. Brenner, T. Wieder, H. Braumüller, C. Boß, C. Schulz, S. Kayser, M. Röcken
Eberhard-Karls-Universitat Tubingen Medizinische Fakultat, Tubingen, Baden-Württemberg, Germany

14.05-14.15            ORAL 226   [POSTER 597 ]
Interim results of a phase I/II, closed label, randomized pilot study for the safety and efficacy of TolaSure gel, 5% w/w targeting aggregated mutant keratin in severe epidermolysis bullosa simplex (TAMES)
A. N. Johnson1, K. McGuire2, A. McCormick2, K. E. Rieger1, L. Broadwater2, S. Jain1, L. Perrone1, J. M. Teng1, J. Y. Tang1, A. S. Chiou1
1Dermatology, Stanford University School of Medicine, Stanford, California, United States, 2BioMendics, LLC, Rootstown, Ohio, United States

14.15-14.25            ORAL 227   [POSTER 626]
Clinical trial of bacteriotherapy as antibiotic-sparing therapy for acne vulgaris
E. S. Burger, S. Brinton, A. O’Neill, T. Nakatsuji, F. Shafiq, O. C. Osuoji, T. Hata, R. L. Gallo
Dermatology, University of California San Diego, La Jolla, California, United States

14.25-14.35            ORAL 228   [POSTER 621 ]
Topical simvastatin for porokeratosis ptychotropica: A randomized, single-blind, split-body, placebo-controlled investigator-initiated trial
Z. Chen, Y. Liu, H. Yu, H. Chen, Y. Yang
Affiliated Hospital for Skin Diseases of Chinese Academy of Medical Sciences, Nanjing, Jiangsu, China

14.35-14.45            ORAL 229   [POSTER 693  ]
Social media as an educational platform for seborrheic dermatitis
S. Fakhraie, R. Chovatiya
Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

14.45-14.55            ORAL 230   [POSTER 691 ]
Visualization of Covid-19 pandemic influence on healthcare routines in dermatology using electronic health record data
J. Ryan Wolf1, L. Zhang2, Y. Xie3, A. Pentland1, B. T. Pentland2
1Dermatology, University of Rochester Medical Center, Rochester, New York, United States, 2College of Business, Michigan State University, East Lansing, Michigan, United States, 3Public Health Sciences, University of Rochester Medical Center, Rochester, New York, United States

14.55-15.05            ORAL 231   [POSTER 692]
Impact of education on illness perception in patients with cutaneous T-cell lymphoma
A. Munjal, O. Pierog, D. Weiner, S. Talluru, A. Burns, S. Rozati
Dermatology, Johns Hopkins University, Baltimore, Maryland, United States

15.05-15.15            ORAL 232   [POSTER 587 ]
Higher IL-10+ T cell and treg cell counts in psoriatic skin are associated with super-response to guselkumab: Data from the phase 3 guide trial
J. Angsana6, K. Kohler6, J. Sendecki6, M. W. Leung6, S. Tabori7, N. Krüger7, S. Wegner7, Y. Personke7, R. Sabat2, K. Wolk2, A. Pinter1, P. Weisenseel3, K. Asadullah2, 8, K. Schäkel4, K. Eyerich5
1Uni. Hosp. Frankfurt am Main, Frankfurt am Main, Germany, 2Charité–Universitätsmedizin Berlin, Berlin, Germany, 3Dermatologikum Hamburg, Hamburg, Germany, 4Heidelberg Uni. Hosp., Heidelberg, Germany, 5Med. Center, Uni. of Freiburg, Freiburg, Germany, 6Janssen R&D LLC, San Diego, California, United States, 7Janssen-Cilag GmbH, Neuss, Germany, 8Dermatological practice, Potsdam, Germany

15.15-15.25              ORAL 233   [POSTER 590 ]
Litifilimab modulates Type 1 interferon (IFN) biomarkers in patients with cutaneous lupus erythematosus (CLE): Result of the LILAC Part B Phase 2 study
V. P. Werth1, R. A. Furie2, E. Milliman3, K. Ferber3, F. Casey3, R. Brown3, D. Raitcheva3, J. Zoghbi3, D. Graham3, G. Kong3, Y. Lahoud3, N. Franchimont3C. Barbey4
1University of Pennsylvania, Philadelphia, Pennsylvania, United States, 2Northwell Health, Great Neck, New York, United States, 3Biogen, Cambridge, Massachusetts, United States, 4Biogen, Baar, Switzerland

15.25-15.35            ORAL 234   [POSTER 669 ]
Examining disparities in melanoma detection: A geospatial analysis of access-to-care
M. M. Tran, T. Vance, S. Yumeen, L. Orsillo, F. N. Mirza, A. Robbins, A. Mehta, O. Wisco
Dermatology, Brown University Warren Alpert Medical School, Providence, Rhode Island, United States

15.35-15.45            ORAL 235   [POSTER 624 ]
Clinical and immune analysis of mesenchymal stromal cells (MSCs) for multiple biologic-resistant psoriasis
S. M. Lwin, S. Solanky, I. Tosi, H. Dawe, J. A. McGrath, C. Giacomini, P. di Meglio, F. Dazzi, C. E. Griffiths
King’s College London, London, United Kingdom

Epidermal Structure and Barrier Function
Room: Room C (Nishiki) – 4F (south tower)
Chairs: Hideyuki Ujiie, Tatiana Efimova, Sandrine Dubrac

13.15-13.25            ORAL 236   [POSTER 766 ]
H3K9me3 methyltransferase SETDB1 controls retrotransposon silencing, DNA methylation, constitutive heterochromatin maintenance and 3D-chromatin structure in epidermal keratinocytes
E. Rozhkova1, G. Chen1, L. Yang2, N. Lau3, V. A. Botchkarev1A. Sharov1
1Dermatology, Boston University, Boston, Massachusetts, United States, 2University of Washington, Seattle, Washington, United States, 3Biochemistry, Boston University, Boston, Massachusetts, United States

13.25-13.35            ORAL 237   [POSTER 737 ]
The role of bisphenol A in atopic dermatitis
D. c. Minzaghi1, V. Cerkvenik Flajs2, S. Dubrac1
1Department of Dermatology, Venereology and Allergology, innsbruck medical university, Innsbruck, Austria, 2Institute of Pathology, Wild Animals, Fish and Bees, Veterinary Faculty, University of Ljubljana, Slovenia, Ljubljana, Slovenia

13.35-13.45            ORAL 238   [POSTER 775 ]
A secretome CRISPR screen identifies SFRP1 and other extracellular proteins regulating epidermal homeostasis
B. Cheng1, T. Bencomo2, C. S. Lee2B. Sun1
1Dermatology, University of California San Diego, La Jolla, California, United States, 2Dermatology, Stanford University School of Medicine, Stanford, California, United States

13.45-13.55            ORAL 239   [POSTER 745 ]
Gasdermin a guards epidermal differentiation and cornification in skin barrier repair: Its role in atopic dermatitis pathogenesis
L. Huang1, S. Li1, S. Lin1, C. Kao5, C. Hong3, 4, C. Lee2L. Yang1, 6
1Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Miaoli County, Taiwan, 2Chang Gung University College of Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan, 3Department of Dermatology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, 4Department of Dermatology, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan, 5Center of General Education, Chang Gung University, Taoyuan, Taiwan, 6Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan

13.55-14.05            ORAL 240   [POSTER 738  ]
Cryo-EM and molecular dynamics of TRPV3 channel in activated state reveal structural features implicated in severe itch and hyperkeratosis
F. Chin1, F. Qin2
1
University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States, 2Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, New York, United States

14.05-14.15            ORAL 241   [POSTER 750 ]
Epidermal expression of Hes1 controls immune response
M. Wakatake, M. Moriyama, S. Goto, Y. Miyake, H. Moriyama
Kinki Daigaku, Higashi-Osaka, Japan

14.15-14.25            ORAL 242   [POSTER 783]
Epidermal-specific ablation of CD271 is linked to altered proliferation and differentiation of keratinocytes during postnatal mouse skin development
M. Quadri1, C. Pellegrini2, M. Mastrangelo2, M. Fargnoli2, C. Vaschieri1, M. Canossa3, M. I. Morasso4, R. Lotti1, C. Pincelli1, A. Marconi1, E. Palazzo1
1DermoLab, University of Modena and Reggio Emilia, Modena, Italy, 2University of L’Aquila, L’Aquila, Italy, 3CIBIO, University of Trento, Trento, Italy, 4Lab Skin Biology, National Institutes of Health, Bethesda, Maryland, United States

14.25-14.35            ORAL 243   [POSTER 772 ]
Structure of a novel endoplasmic reticulum-desmosome complex
N. Bharathan1, W. Giang1, J. Aaron3, S. Khuon3, T. Chew3, A. Weigel3, S. Saalfeld3, W. Vogl2, S. N. Stahley1, A. P. Kowalczyk1
1Dermatology, Penn State College of Medicine, Hershey, Pennsylvania, United States, 2Cellular & Physiological Sciences, The University of British Columbia, Vancouver, British Columbia, Canada, 3Howard Hughes Medical Institute Janelia Farm Research Campus, Ashburn, Virginia, United States

14.35-14.45            ORAL 244   [POSTER 697 ]
The overexpression of sphingomyelin deacylase in murine epidermis elicits a ceramide deficiency and provokes atopic dermatitis-like skin eruptions
M. Kimura1, M. Takada2, M. Komine1, H. Tsuda3, M. Ohtsuki1, G. Imokawa2
1Dermatology, Jichi Ika Daigaku, Shimotsuke, Tochigi, Japan, 2Utsunomiya Daigaku, Utsunomiya, Tochigi, Japan, 3Division of Human Genetics Center for Molecular Medicine, Jichi Ika Daigaku, Shimotsuke, Tochigi, Japan

14.45-14.55            ORAL 245   [POSTER 723]
Common and different roles of dermokine in skin diseases based on mouse genetic background
K. Kawate, T. Shimizu, T. Chino, N. Oyama, M. Hasegawa
Department of Dermatology, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan

14.55-15.05            ORAL 246   [POSTER 751 ]
Regulation of epidermal homeostasis by centrosomal protein Cep43
C. C. Yokoyama1, M. Colonna2
1Internal Medicine, Division of Dermatology, Washington University in St Louis, St Louis, Missouri, United States, 2Pathology & Immunology, Washington University in St Louis, St Louis, Missouri, United States

15.05-15.15            ORAL 247   [POSTER 774 ]
Receptor tyrosine kinase EPHA2 is required for epidermal barrier homeostasis
B. Shi, T. Selph, K. Russell, T. Mahi, E. Khan, I. Martinez, G. Sinchi-Paucar, M. Liu, H. Peng, B. E. Perez White
Northwestern University, Chicago, Illinois, United States

15.15-15.25            ORAL 248   [POSTER 749 ]
TNF-α promotes psoriasis-related keratinocytes dedifferentiation through dual regulation of YAP and NOTCH1 signaling
Z. Yu1, Y. Shi2
1Shanghai Tenth People’s Hospital, Shanghai, China, 2Shanghai Skin Diseases Hospital, Shanghai, China

15.25-15.35            ORAL 249   [POSTER 796  ]
Actin dependent regulation of epidermal differentiation and barrier formation
M. Ruebsam1, A. Bhosale1, F. Tellkamp2, T. Matsui3, M. Amagai4, M. Krüger2, C. M. Niessen1
1Department Cell Biology of the Skin & CECAD, Universitat zu Koln, Köln, Nordrhein-Westfalen, Germany, 2Institute for Genetics, Universitat zu Koln, Köln, Nordrhein-Westfalen, Germany, 3School of Bioscience and Biotechnology, Tokyo Koka Daigaku, Hachioji, Tokyo, Japan, 4Department of Dermatology, Keio University School of Medicine, Tokyo, Japan

15.35-15.45            ORAL 250   [POSTER 797  ]
Crosstalk between adherens junctions and desmosomes and associated cytoskeletons controls epidermal adhesion dynamics and mechanical resilience
H. Zhang1, M. Ruebsam1, R. Püllen2, K. Green3, R. Merkel2, B. Hoffmann2, S. Wickström4, 5C. M. Niessen1
1Cell Biology of the Skin and CECAD, Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany, 2Institute of Biological Information Processing, IBI-2: Mechanobiology, Forschungszentrum Julich GmbH, Julich, Nordrhein-Westfalen, Germany, 3Departments of Pathology and Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States, 4Department of Cell and Tissue Dynamics, Max Planck Institute for Molecular Biomedicine, Münster, Germany, 5Stem Cells and Metabolism Research Program, Helsingin yliopisto Laaketieteellinen tiedekunta, Helsinki, Uusimaa, Finland

Innate Immunity, Microbiology, Microbiome II
Room: Room D (Ohgi) – 4F (south tower)
Chairs: Nan-Lin Wu, Anna De Benedetto and Bernhard Homey

13.15-13.25            ORAL 251   [POSTER 960  ]
A metabolite produced by skin commensal bacteria enhances epithelial integrity in human keratinocyte
F. A. Aldehalan, A. J. Mcbain, C. O’Neill
The University of Manchester Faculty of Biology Medicine and Health, Manchester, United Kingdom

13.25-13.35            ORAL 252   [POSTER 956 ]
Epidermal keratinocyte-specific STAT3 deficiency aggravated atopic dermatitis-like skin inflammation in mice through TSLP upregulation
Z. Wang, X. Man
Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

13.35-13.45            ORAL 253   [POSTER 966 ]
Cx26 mutation in keratinocytes is responsible for susceptibility to candida albicans in the mouse model of keratitis-ichthyosis-deafness syndrome
A. Mostafa1, T. Murata2, H. Doi1, G. Egawa1, K. Kabashima1
1Dermatology, Graduate School of Medicine Kyoto University, Kyoto, Japan, 2Dermatology, Hyogo Medical University, Nishinomiya, Japan

13.45-13.55            ORAL 254   [POSTER 983 ]
Corynebacterium diphtheriae causes keratinocyte-intrinsic ribotoxic stress and NLRP1 inflammasome activation in a model of cutaneous diphtheria
K. Robinson1, G. Toh2, K. Tham1, J. E. Common1, F. Zhong2
1ASRL, Singapore, Singapore, 2NTU, Singapore, Singapore

13.55-14.05            ORAL 255   [POSTER 917 ]
Amphiregulin-producing innate lymphoid cells promote barrier response after mechanical damage
T. Kobayashi1, M. Li2, D. Asanuma3, N. Shigeyuki3, K. Hirose3, K. Fujita2, K. Moro1,2
1RIKEN, Yokohama, Japan, 2Osaka University, Osaka, Japan, 3Tokyo University, Tokyo, Japan

14.05-14.15            ORAL 256   [POSTER 939 ]
Acid mantle of the stratum corneum is a shield against bacterial entry into the underlying epidermal layers
Y. Ito1, K. Fukuda2, R. Ozawa1, M. Amagai1, 2
1Dermatology, Keio University School of Medicine, Tokyo, Japan, 2Skin Homeositasis, RIKEN IMS, Yokohama, Japan

14.15-14.25            ORAL 257   [POSTER 945]
Galectin-12 Regulates the Immune Response in Skin Through Sebaceous Glands
F. Lin1, 2, Y. Huang1, 2, Y. Lo4, F. Liu1, 2, 3
1Graduate Institute of Immunology, National Taiwan University, Taipei, Taiwan, 2Institute of Biomedical Sciences Academia Sinica, Taipei, Taiwan, 3University of California Davis Department of Dermatology, Sacramento, California, United States, 4Fu Jen Catholic University, Taipei, Taiwan

14.25-14.35            ORAL 258   [POSTER 923 ]
Microbially-induced transgenerational epigenetic inheritance via the immune system regulates sebum secretion and the chemical barrier
J. Harris1, 2, N. Trigg3, B. Goshu1, C. Conine3, E. Grice2, T. Kambayashi1
1Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States, 2Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States, 3Neonatology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

14.35-14.45            ORAL 259   [POSTER 977 ]
IL-23/IL23R promote macrophage pyroptosis and Th1/Th17 cell differentiation in mycobacterial infection
C. Wang, T. Liu, Z. Wang, Q. Zhao, Z. Mi, H. Liu, F. Zhang
Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Jinan, China

14.45-14.55            ORAL 260   [POSTER 926 ]
The role of HTR2A on langerhans cells in skin inflammation
Y. Tan1, 4, C. Yeh4, S. Su4, C. Lu4, C. Tsai4, H. Weng2, 3, T. Tsai2, Y. Lee1, 4
1National Yang Ming Chiao Tung University – Yangming Campus, Taipei, Taiwan, 2National Taiwan University Hospital, Taipei, Taiwan, 3Taipei Medical University, Taipei, Taiwan, 4Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

14.55-15.05            ORAL 261   [POSTER 981  ]
Adiponectin downregulation in lesional skin contributes to enhanced mTORC1 activation and skin inflammation in rosacea.
J. Suh4, 1, 2, S. Jin4, 1, 2, Y. Lee1, 2, N. Li4, 1, 2, J. Oh1, 2, E. Kim1, 2, S. Kim3, S. Lee4, 1, 2, D. Lee4, 1, 2, S. Cho4, 2, J. Chung4, 1, 2
1Dermatology, Seoul National University Hospital, Jongno-gu, Seoul, Korea (the Republic of), 2Institute of human-environmental interface biology, Seoul, Korea (the Republic of), 3Physiology, Seoul National University College of Medicine, Seoul, Korea (the Republic of), 4Dermatology, Seoul National University College of Medicine, Seoul, Korea (the Republic of)

15.05-15.15            ORAL 262   [POSTER 1050 ]
Neutrophil-intrinsic NLRP12 and caspase-8 signal for inflammasome-mediated host defense against staphylococcus aureus skin infections
M. P. Alphonse1, H. Liu1, D. Dikeman1, R. V. Ortines1, Y. Wang1, Q. Liu1, C. Youn1, G. Wang1, E. A. Cahill1, D. Prifti1, A. Cox2, L. A. Garza1, L. Miller1, 3, N. Archer1
1Dermatology, Johns Hopkins Medicine, Baltimore, Maryland, United States, 2Molecular Microbiology and Immunology, Johns Hopkins Medicine, Baltimore, Maryland, United States, 3Janssen Research and Development LLC, Spring House, Pennsylvania, United States

15.15-15.25            ORAL 263   [POSTER 959 ]
Identification of novel innate immune cells in human epidermis
T. Sato, Y. Ogawa, S. Shimada, T. Kawamura
Department of Dermatology, Yamanashi Daigaku Igakubu Daigakuin Sogo Kenkyubu Igakuiki, Chuo, Yamanashi, Japan

15.25-15.35            ORAL 264   [POSTER 1006]
Single-cell and spatial architecture of human tissue granulomas reveals an aberrant immune-regulatory program underlying sarcoidosis
A. Redl1, 2, T. Krausgruber2, D. Barreca2, C. Lim3, K. Doberer4, L. Unterluggauer1, L. Kleissl5, C. Mayerhofer1, A. Kopf5, T. Weichhart3, C. Bock2, G. Stary1
1Department of Dermatology, Medizinische Universitat Wien, Wien, Austria, 2Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Wien, Austria, 3Institute of Medical Genetics, Medizinische Universitat Wien, Wien, Austria, 4Department of Nephrology, Medizinische Universitat Wien, Wien, Austria, 5Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria

15.35-15.45            ORAL 265   [POSTER 1048 ]
NK cell populations are major contributors to pathogenesis in hidradenitis suppurativa (HS)
C. Raman1, M. Kashyap1, B. Mishra2, J. Deshane3, S. Mukhtar2, C. A. Elmets1, M. Athar1
1Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, United States, 2Biological Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States, 3Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States

Pigmentation and Melanoma
Room:
Room E (Moonlight) – 43F (main tower)
Chairs: Nikolas Haass, Niroshana Anandasabapathy and Katia Boniface

13.15-13.25            ORAL 266   [POSTER 1224 ]
AhR regulates the efferocytosis and polarization of tumor-associated macrophages through ALKAL1-mediated MerTK activation and promotes melanoma progression
N. Wu, J. Tao
Doctor, Huazhong University of Science and Technology, Wuhan, Hubei, China

13.25-13.35            ORAL 267   [POSTER 1278 ]
Blocking tumor-intrinsic caspase-1 inflammasome sensitizes melanoma response to anti-PD1 therapy by rejuvenating dysfunctional CD8 T cells
P. K. Vaddi1, D. Osborne1, D. Ravindran-Menon1, T. Yamauchi1, Z. Zhai1, M. Fujita1,2, 3
1Dermatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States, 2Department of Veterans Affairs Medical Center, VA Eastern Colorado Health Care System, Aurora, Colorado, United States, 3Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

13.35-13.45            ORAL 268   [POSTER 1216 ]
SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation
X. Yi, W. Guo, H. Wang, Y. Yang, C. Li
Air Force Medical University, Xi’an, Shaanxi, China

13.45-13.55            ORAL 269   [POSTER 1191  ]
Immunotherapy with 4-1BBL-expressing iPSC-derived proliferating myeloid cells amplifies antigen-specific T cell infiltration in advanced melanoma
H. Kuriyama1, T. Kimura1, H. Kanemaru1, A. Miyashita1, T. Inozume2, R. Zhang3, Y. Uemura3, S. Fukushima1
1Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Kumamoto, Japan, 2Department of Dermatology, Chiba University, Chiba, Japan, 3Division of Cancer Immunotherapy, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan

13.55-14.05            ORAL 270   [POSTER 1282 ]
Basal cell carcinoma pigmentation is associated with melanocyte proliferation and expression of the melanocyte mitogens endothelin 1 and 2 by tumor cells
E. A. Pedersen1, M. A. Grachtchouk1, M. E. Verhaegen1, L. Syu1, P. W. Harms1, M. Gharaee-Kermani1, F. Ma1, J. Gudjonsson1, M. Ito2, A. Dlugosz1
1University of Michigan, Ann Arbor, Michigan, United States, 2NYU Langone Health, New York, New York, United States

14.05-14.15            ORAL 271   [POSTER 1240 ]
Distinct cAMP signaling microdomains differentially regulate melanosomal pH and pigmentation
D. Zhou1, M. Yusupova1, J. You1, J. Gonzalez-Guzman2, M. Ghanta2, H. Pu4, Z. Abdel-Malek3, J. D’Orazio4, S. Ito5, K. Wakamatsu5, M. Harris2, J. Zippin1, 6, 7
1Dermatology, Weill Cornell Medicine, New York, New York, United States, 2The University of Alabama at Birmingham Department of Cell Developmental and Integrative Biology, Birmingham, Alabama, United States, 3Dermatology, University of Cincinnati, Cincinnati, Ohio, United States, 4Pediatrics, University of Kentucky, Lexington, Kentucky, United States, 5Institute for Melanin Chemistry, Fujita Ika Daigaku, Toyoake, Aichi, Japan, 6Pharmacology, Weill Cornell Medicine, New York, New York, United States, 7Englander Institute of Precision Medicine, Weill Cornell Medicine, New York, New York, United States

14.15-14.25            ORAL 272   [POSTER 1274 ]
Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis
G. Hashemi, L. Sormani Le Bourhis, J. Dight, C. Zhou, E. Roy, K. Khosrotehrani
The University of Queensland, Saint Lucia, Queensland, Australia

14.25-14.35            ORAL 273   [POSTER 1189 ]
PD-1 blockade may promote not only the reactivation of preexisting tumor-specific T cell clones but also the infiltration of new clones
T. Inozume1, 4, 3, J. Nagasaki2, 4, M. Kawazu4, T. Kawamura3, K. Yamashita5, Y. Togashi2, 4
1Dermatology, Chiba University, Chiba, Japan, 2Tumor Microenvironment, Okayama University, Okayama, Japan, 3Dermatology, University of Yamanashi, Kofu, Japan, 4Research Institute, Chiba Cancer Center, Chiba, Japan, 5KOTAI Biotechnologies Inc, Osaka, Japan

14.35-14.45            ORAL 274   [POSTER 1204 ]
Immunogenic cell death by inhibition of glucose-6-phosphate dehydrogenase enhances the efficacy of immunotherapy in malignant melanoma
M. Nakamura, M. Yoshimitsu, T. Magara, S. Kano, H. Kato, A. Morita
Department of Geriatric and Environmental Dermatology, Nagoya Shiritsu Daigaku Daigakuin Igaku Kenkyuka Igakubu, Nagoya, Aichi, Japan

14.45-14.55            ORAL 275   [POSTER 1220 ]
Cytosolic acetyl-CoA drives tumor immune evasion via the epigenetic regulation of PD-L1 in melanoma
H. Wang, W. Guo, X. Yi, Y. Yang, C. Li
Xijing Hospital, Xian, Shaanxi, China

14.55-15.05            ORAL 276   [POSTER 1262 ]
Immuno-apoptotic priming to enhance the efficacy of immunotherapies in melanoma
N. Mukherjee, R. Tobin, E. Katsnelson, M. McCarter, D. Norris, Y. Shellman
University of Colorado, Denver, Colorado, United States

15.05-15.15            ORAL 277   [POSTER 1261 ]
ER stress facilitates anti-cancer immunosurveillance and improves immunotherapy efficacy in melanoma
Y. Yang, S. Guo, H. Wang, C. Li, X. Yi, W. Guo
Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China

15.15-15.25            ORAL 278   [POSTER 1275 ]
A mutual repression between MITF and neural transcription factors specifies the fate of schwann cell precursors
A. Kawakami1, M. Hejna2, M. Hoang3, K. Kabashima1, J. Song2, D. E. Fisher4
1Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2Department of Physics, University of Illinois, Urbana, Illinois, United States, 3Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States, 4Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, United States

15.25-15.35            ORAL 279   [POSTER 1214  ]
Targeting SHOC2 disrupts MEK/ERK signaling and inhibits viability of NRAS-mutant human melanoma cells.
R. A. Francois1, L. Young2, F. McCormick2
1Departments of Dermatology and Pathology, University of California San Francisco, San Francisco, California, United States, 2Helen Diller Family Comprehensive Cancer Center and Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States

15.35-15.45            ORAL 280   [POSTER 1181 ]
Delivery of costimulatory molecules and immunostimulatory cytokines leads to targeted and systemic immune activation against melanoma in vivo
K. M. Luly1, J. J. Green1, J. C. Sunshine2, 1, S. Y. Tzeng1
Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States, 2Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

Late-Breaking Abstracts
Room: Room F (Harmony) – 44F (main tower)
Chairs: Manabu Ohyama, Wendy Weinberg, Sabine Eming

13.15-13.25 ORAL 281  [LB 1658]
Eco-evolutionary profiling of the earliest steps in the skin carcinogenesis
S. Avdieiev1, 3, L. Tordesillas2, K. M. Prieto-Sarmiento2, O. Chavez Chiang2, Z. Chen4, L. Silva Simoes1, Y. Chen4, N. Andor1, C. Whelan1, 3, R. Gatenby1, 3, E. Flores5, 3, J. Brown1, 3, K. Tsai2, 3
1Integrated Mathematical Biology, Moffitt Cancer Center, Tampa, Florida, United States, 2Tumor Biology, Moffitt Cancer Center, Tampa, Florida, United States, 3Cancer Biology and Evolution Program, Moffitt Cancer Center, Tampa, Florida, United States, 4Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States, 5Molecular Oncology, Moffitt Cancer Center, Tampa, Florida, United States

13.25-13.35 ORAL 282 [LB 1763 ]
Combinatorial BRD9 and SMO targeting synergistically suppress UV-induced BCC tumor burden in a murine model of Gorlin syndrome (GS)
A. Kim, Y. Zhu, D. Chen, M. Elmais, M. Athar, D. R. Bickers
Columbia University Irving Medical Center, New York, New York, United States

13.35-13.45 ORAL 283  [LB 1645 ]
IL-9 sensitizes human pathogenic Th2 cells to pro-inflammatory IL-18 signals in atopic dermatitis
S. Schärli1, F. Luther1, O. Steck1, J. Thyssen2, N. Bertschi1, C. Schlapbach1
1Department of Dermatology, Inselspital Universitatsspital Bern, Bern, Bern, Switzerland, 2Department of Dermatology and Allergology, Gentofte Hospital, Hellerup, Hovedstaden, Denmark

13.45-13.55 ORAL 284  [LB 1751 ]
Downstream effects of IL-13Rα1 blockade on type 2 inflammation and Th1 immune axis activation in atopic dermatitis
S. V. Reddy1, Z. A. Bordeaux1, A. Rajeh2, D. M. Sivaloganathan2, H. Cornman2, A. Kambala2, J. Adams1, F. Cevikbas3, S. Kwatra2, M. Kwatra1
1Anesthesiology, Duke University School of Medicine, Durham, North Carolina, United States, 2Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States, 3ASLAN Pharmaceuticals Pte Ltd, San Mateo, California, United States

13.55-14.05 ORAL 285 [LB 1672 ]
Senescent Melanocytes in Nevus Skin Stimulate Hair Growth
X. Wang1, R. Ramos1, N. Shettigar1, Q. Nie2, M. Plikus1
1Developmental and Cell Biology, University of California Irvine, Irvine, California, United States, 2Mathematics, University of California Irvine, Irvine, California, United States

14.05-14.15 ORAL 286 [LB 1754 ]
Treatment of human palmoplantar keratoderma skin equivalents with a TRPV3 antagonist, KM-001
M. Caley1, M. Idrissi1, L. Braiman2, E. Brener2E. O’Toole1
1Centre for Cell Biology and Cutaneous Research, Queen Mary University of London, London, United Kingdom, 2Kamari Pharma, Ness Ziona, Israel

14.15-14.25 ORAL 28[LB 1640 ]
Dynamic profiling of desmoglein 3-reactive T helper cells in pemphigus vulgaris
K. Volkmann1, 2, J. Hinterseher1, A. Polakova1, D. Didona1M. Hertl1
1Department of Dermatology and Allergology, Philipps-Universitat Marburg, Marburg, Hessen, Germany, 2Bundesinstitut fur Arzneimittel und Medizinprodukte, Bonn, Nordrhein-Westfalen, Germany

14.25-14.35 ORAL 288 [LB 1734 ]
GPNMB supresses the antimicrobial activity of macrophages through targeting VAMP8
Z. Yan1, N. Dang1, H. Liu2, F. Zhang2
1Department of Dermatology, Shandong Provincial Hospital, Jinan, Shandong, China, 2Shandong First Medical University, Jinan, Shandong, China

14.35-14.45 ORAL 289 [LB 1756 ]
The Role of cNOS in UV-induced DNA Damage and Repair
S. Wu1, 4, V. Bahamondes Lorca1, 2, L. Tong1, 3
1Edison Biotechnology Institute, Ohio University, Athens, Ohio, United States, 2Tecnología Médica, Universidad de Chile, Santiago de Chile, Chile, 3Nationwide Children’s Hospital, Columbus, Ohio, United States, 4Chemsitry and Biochemistry, Ohio University, Athens, Ohio, United States

14.45 PM-14.55 ORAL 290 [LB 1654 ]
Mitochondrial transfer from cancer cells induces pro-tumorigenic features in skin fibroblasts
M. Cangkrama, H. Liu, J. Whipman, C. Gaebelein, J. Vorholt, S. Werner
Eidgenossische Technische Hochschule Zurich, Zurich, Zürich, Switzerland

14.55-15.05 ORAL 291 [LB 1671 ]
Large-scale skin scRNA-seq profiling highlights distinct Body Site-specific ligand-receptor interactions and pathways in keratinocytes
R. Wasikowski1, M. T. Patrick1, Q. Li1, Q. Nie2, B. Andersen3, M. Plikus2, J. M. Kahlenberg4, A. Billi1, L. Tsoi1, J. Gudjonsson1
1Dermatology, University of Michigan, Ann Arbor, Michigan, United States, 2Developmental and Cell Biology, University of California Irvine, Irvine, California, United States, 3Medicine, University of California Irvine, Irvine, California, United States, 4Rheumatology, University of Michigan, Ann Arbor, Michigan, United States

15.05-15.15 ORAL 292 [LB 1722 ]
Ablating ATP2C1 in human keratinocytes impairs intercellular adhesion, disrupts epidermal integrity, and reveals therapeutic targets for Hailey-Hailey disease
J. L. Ayers1, A. Tiwaa1, M. K. Sarkar2, J. Gudjonsson2, C. L. Simpson1
1Dermatology, University of Washington, Seattle, Washington, United States, 2Dermatology, University of Michigan, Ann Arbor, Michigan, United States

15.15-15.25 ORAL 293 [LB 1735 ]
Utilizing Large-scale Sequencing to Depict Changes in Immune Cells during Cancer Immunoediting in Epidermal Neoplasms
X. Fan, D. R. Roop
Dermatology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States

15.25-15.35 ORAL 294 [LB 1792 ]
CCL2 restores adult cells to regenerate hair follicles by microenvironmental regulation
W. Wu1, 2, W. Zhou3, J. Jiang1, M. Wang1, J. Zhang1, X. Shen1, Q. Tang2, H. Liu2, L. Yang1, M. Lei1
1Bioengineering, Chongqing University, Chongqing, China, 2Chongqing University Three Gorges Hospital, Chongqing, China, 3Chongqing University Cancer Hospital, Chongqing, China

15.35-15.45 ORAL 295 [LB 1778 ]
Wound Closure in diabetic db/db mice is facilitated by autologous hair-follicle associated pluripotent (HAP)stem cells
A. Hasegawa1, 2, K. Obara2, n. takaoka1, k. shirai2, Y. Hamada2, n. arakawa2, r. aki2, R. Hoffman3, 4, Y. Amoh2
1dermatology, Kitasato University Graduate School of Medical Science, Sagamihara, Kanagawa, Japan, 2dermatology, Kitasato Daigaku Igakubu, Sagamihara, Kanagawa, Japan, 3Anti Cancer Inc, San Diego, California, United States, 4Surgery, University of California San Diego, La Jolla, California, United States

Room: Room A (Concord Ballroom) – 5F  (main tower)

HOSTED BY: Prof. Kenji Kabashima, JSID President and Prof. Dong-Youn Lee, KSID President

AGENDA:
Post-Meeting Presidential Remarks
– International Societies for Investigative Dermatology (ISID),
Dr. Russell Hall
– Australasian Society for Dermatology Research (ASDR),
Prof. Johannes Kern
– European Society for Dermatological Research (ESDR),
Prof. Sabine Eming
– Taiwanese Society for Investigative Dermatology (TSID),
Prof. Sung-Jan Lin
– Society for Investigative Dermatology (SID),
Dr. Lynn Cornelius

A message about ISID 2028
from ESDR President, Prof. Sabine Eming

Conclusion

Room: Room A (Concord Ballroom) – 5F  (main tower)

AGENDA:
16:05 – COVID-19 vaccines related cutaneous reactions
Presented by: Chun-Bing Chen (Chinese Taipei)
Chair: Riichiro Abe (Japan)

16:21 – Altering cell mechanics to inhibit melanoma cell migration, invasion and metastasis
Presented by: Nikolas Haass (Australia)
Chair: Chia-Yu Chu (Chinese Taipei)

16:37 – Unravelling the NLRP1 inflammasome through the study of Genodermatoses
Presented by: Kenneth Lay (Singapore)
Chair: John Common (Singapore)

16:53 – Role of ATP-P2X7 axis in Melanogenesis
Presented by: Sang-Ho Oh (Korea)
Chair: Weon Ju Lee (Korea)

17:09 – Bosentan versus nifedipine in the treatment of vasculopathy in systemic Sclerosis: A randomized clinical trial
Presented by: Trinh Ngoc Phat (Vietnam)
Chair: Qianjin Lu (China)

17:25 – SJS/TEN; Thailand perspective
Presented by: Pawinee Rerknimitr (Thailand)
Chair: Victoria Mar (Australia)

17:41 – Neuron-immunopathology in Psoriasis
Presented by: Honglin Wang (China)
Chair: TBD

Satellite Symposium
Title: International Symposium On Cutaneous Lymphoma

Room: Room G (Takao) 42F
Program: Download the program HERE
Website: HERE

Organizers: Makoto Sugaya (Chair), Kazuyasu Fujii, Taku Fujimura, Hideki Fujita, Toshihisa Hamada, Tomomitsu Miyagaki, Takatoshi Shimauchi, Rei Watanabe

Satellite Symposium
Room:
Room B ((Eminence Hall)

Title: New fragrance material safety research: Dermal sensitization and photoallergenicity

Program: TBA

Organizers: Anne Marie Api, PhD, Isabelle Lee, PhD, Gretchen Ritacco, MS

Satellite Symposium
Room:
Room E (Moonlight)

Title: Satellite Symposium on Cutaneous Surgery

Program: TBA